Systemic lupus erythematosus

M13_SLE

systemic lupus erythematosus: An autoimmune multi-organ disease typically associated with vasculopathy and autoantibody production. Most patients have antinuclear antibodies (ANA). The presence of anti-dsDNA or anti-Smith antibodies are highly-specific.

Suggest a new description

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — M32 Hospital discharge: ICD-9 — 7100 Hospital discharge: ICD-8 — 7341 Cause of death: ICD-10 — M32 Cause of death: ICD-9 — 7100 Cause of death: ICD-8 — 7341 2 out of 7 registries used, show all original rules.	1546
4. Check minimum number of events None	1546
5. Include endpoints None	1546
6. Filter based on genotype QC (FinnGen only)	1385

Control definitions (FinnGen only)

Control exclude: M13_SYSTCONNECT

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: M30-M36
Name in latin: Lupus erythematosus disseminatus (LED)

NAME	M13_SLE
CONTROL_EXCLUDE	M13_SYSTCONNECT
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	M32
HD_ICD_9	7100
HD_ICD_8	7341
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	M32
COD_ICD_9	7100
COD_ICD_8	7341
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Systemic lupus erythematosus based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	1385	1137	248
Unadjusted period prevalence (%)	0.35	0.40	0.11
Median age at first event (years)	45.82	44.00	54.16

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
1442: Matched controls
14420

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

L04AX01

ATC

azathioprine; systemic

24.7

307.7

411

229

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

12.6

307.7

448

498

L93.0

ICD-10 Finland

Discoid lupus erythematosus

117.0

307.7

184

L04AA06

ATC

mycophenolic acid; systemic

52.5

307.7

270

M32.8

ICD-10 Finland

Other forms of systemic lupus erythematosus

+∞

307.7

335

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

36.8

307.7

991

813

M35.0

ICD-10 Finland

Sicca syndrome [Sjögren]

133.1

307.7

225

P01BA02

ATC

hydroxychloroquine; oral

62.1

307.7

1046

588

M32.9

ICD-10 Finland

Systemic lupus erythematosus, unspecified

13041.7

307.7

1164

M35.9

ICD-10 Finland

Systemic involvement of connective tissue, unspecified

1285.5

307.7

305

L04AX03

ATC

methotrexate; systemic

8.7

297.4

471

765

M32.0

ICD-10 Finland

Drug-induced systemic lupus erythematosus

+∞

262.8

244

M32.1

ICD-10 Finland

Systemic lupus erythematosus with organ or system involvement

+∞

255.0

237

H02AB06

ATC

prednisolone; systemic

6.6

221.2

1125

5066

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

5.3

212.4

928

3651

7100A

ICD-9 Finland

Diffuse diseases of connective tissue, Systemic lupus erythematosus

+∞

193.2

181

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

7.3

192.1

326

554

M32

ICD-10 Finland

Systemic lupus erythematosus

+∞

189.9

178

H02AB07

ATC

prednisone; oral

5.5

183.4

459

1127

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

7.2

179.4

304

514

M05BA04

ATC

alendronic acid; oral

6.0

157.2

327

673

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

5.9

156.9

331

690

N08.5*M32.1

ICD-10 Finland

Glomerular disorders in systemic lupus erythematosus

+∞

156.1

147

L88

ICPC

Rheumatoid/seropositive arthritis

8.7

150.4

205

269

L01BA01

ATC

methotrexate; systemic

9.3

143.2

184

224

73410

ICD-8 Finland

Diffuse diseases of connective tissue, Systemic lupus erythematosus

+∞

142.1

134

XX9XE

NOMESCO Finland

Other ultrasound examination

28.9

128.9

GD1AA

NOMESCO Finland

Thorax X-ray examination

3.7

123.7

936

4813

L04AD01

ATC

ciclosporin; systemic

15.2

122.2

110

KA3AT

NOMESCO Finland

Biopsy of kidney with ultrasound guidance

19.5

120.2

M35.1

ICD-10 Finland

Other overlap syndromes

+∞

116.2

110

L04AA01

ATC

[U] ciclosporin

18.2

109.1

C08CA05

ATC

nifedipine; systemic

6.2

104.6

194

352

R50.9

ICD-10 Finland

Fever, unspecified

3.6

89.7

375

1286

D68.8

ICD-10 Finland

Other specified coagulation defects

14.0

87.6

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

4.1

84.9

271

770

M05.8

ICD-10 Finland

Other seropositive rheumatoid arthritis

5.2

83.3

185

394

H02AB04

ATC

methylprednisolone; systemic

3.4

78.4

354

1264

P01BA01

ATC

chloroquine; systemic

25.0

74.8

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

3.5

74.7

310

1047

C03CA01

ATC

furosemide; systemic

2.8

73.7

524

2412

ZX120

NOMESCO Finland

Intravenous

3.9

73.1

247

727

ND2DA

NOMESCO Finland

Bilateral hand X-ray examination

8.8

69.2

107

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

5.2

65.9

143

297

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.6

64.9

564

2838

M35.3

ICD-10 Finland

Polymyalgia rheumatica

8.7

61.7

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

3.4

59.5

240

789

A49.9

ICD-10 Finland

Bacterial infection, unspecified

3.4

56.3

229

755

Z01.0

ICD-10 Finland

Examination of eyes and vision

2.7

55.9

382

1688

J01MA12

ATC

levofloxacin; systemic

2.7

53.8

352

1517

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

3.3

53.5

233

800

J18.9

ICD-10 Finland

Pneumonia, unspecified

2.5

53.5

446

2164

TPH04

NOMESCO Finland

Cathetrisation of vein

2.6

53.3

421

1991

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

2.8

53.2

332

1396

NF1AE

NOMESCO Finland

Hip joint ultrasound examination

6.3

49.5

141

D69.3

ICD-10 Finland

Idiopathic thrombocytopenic purpura

15.1

49.5

E0000UV, ,

ATC

2.3

49.3

749

4674

G05.8*M32.1

ICD-10 Finland

Encephalitis in systemic lupus erythematosus

+∞

48.2

M13.9

ICD-10 Finland

Arthritis, unspecified

3.5

47.7

179

558

A02BC02

ATC

pantoprazole; systemic

2.5

47.5

1115

8290

NH3DA

NOMESCO Finland

Bilateral foot X-ray examination

6.5

47.4

127

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

2.2

46.7

771

4939

D07AB08

ATC

desonide; topical

3.0

46.5

241

912

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

8.1

46.2

I15.1

ICD-10 Finland

Hypertension secondary to other renal disorders

11.2

46.1

H26.3

ICD-10 Finland

Drug-induced cataract

15.0

46.1

H04.10

ICD-10 Finland

Dry eye syndrome

2.8

45.9

282

1169

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

8.2

45.8

L93.1

ICD-10 Finland

Subacute cutaneous lupus erythematosus

237.4

45.2

B01AA03

ATC

warfarin; systemic

2.7

45.2

281

1171

SBA10

NOMESCO Finland

Measurement of salivary flow rate

11.5

45.1

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

5.1

44.0

203

N08.5

ICD-10 Finland

Glomerular disorders in systemic connective tissue disorders

+∞

44.0

J01FF01

ATC

clindamycin; systemic

2.3

43.6

487

2650

1XC02, ,

NOMESCO Finland

14.8

43.5

D69.6

ICD-10 Finland

Thrombocytopenia, unspecified

7.6

42.6

I73.0

ICD-10 Finland

Raynaud syndrome

7.4

42.2

N18.0

ICD-10 Finland

End-stage renal disease

15.2

41.8

Z94.0

ICD-10 Finland

Kidney transplant status

12.4

40.3

M80.4

ICD-10 Finland

Drug-induced osteoporosis with pathological fracture

16.6

40.2

M79.0

ICD-10 Finland

Rheumatism, unspecified

4.5

40.1

101

236

R4120

NOMESCO Finland

Occupational therapy

3.4

39.2

151

477

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

4.0

39.1

116

307

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

2.3

38.4

392

2037

M34.9

ICD-10 Finland

Systemic sclerosis, unspecified

387.3

38.2

L04AA13

ATC

[U] leflunomide

5.5

37.8

143

N02AX02

ATC

tramadol; systemic, rectal

2.0

37.6

681

4400

O99.1

ICD-10 Finland

Other diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism complicating pregnancy, childbirth and the puerperium

12.7

36.7

J99.1*M32.1

ICD-10 Finland

Respiratory disorders in systemic: lupus erythematosus

+∞

36.6

KA1AE

NOMESCO Finland

Kidney ultrasound examination

6.3

36.3

102

Z49.1

ICD-10 Finland

Extracorporeal dialysis

10.5

36.1

M05BA07

ATC

risedronic acid; oral

4.6

35.9

197

M05BB03

ATC

alendronic acid and colecalciferol; oral

5.6

35.8

128

O99.89

ICD-10 Finland

Other specified diseases and conditions complicating pregnancy, childbirth and the puerperium

5.7

35.6

125

B07.9

ICD-10 Finland

Verruca simplex

4.3

35.5

237

M06.9

ICD-10 Finland

Rheumatoid arthritis, unspecified

4.5

35.0

205

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

3.6

34.5

123

369

127

Kela drug reimbursment

Transplant complication

8.4

34.3

D07AC01

ATC

betamethasone; topical

2.0

34.2

604

3831

Z01.8

ICD-10 Finland

Other specified special examinations

2.1

33.9

411

2272

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.8

33.9

196

780

J84.8

ICD-10 Finland

Other specified interstitial pulmonary diseases

11.5

33.7

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

2.6

33.5

227

977

G73.7*M32.1

ICD-10 Finland

Myopathy in systemic lupus erythematosus

+∞

33.5

A11CC03

ATC

alfacalcidol; systemic

5.8

33.4

111

318

Kela drug reimbursment

Teriparatide

13.1

33.2

J01MA02

ATC

ciprofloxacin; systemic

2.0

33.2

591

3749

M05BX04

ATC

denosumab; parenteral

3.2

33.2

145

494

XF400

NOMESCO Finland

ECG with 12 standard connections

2.4

32.9

254

1162

L30.9

ICD-10 Finland

Dermatitis, unspecified

2.1

32.9

390

2134

KAS10

NOMESCO Finland

Allogenic transplantation of kidney from cadaver donor

12.6

32.5

L99

ICPC

Musculoskeletal disease other

5.1

32.4

140

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

3.0

32.1

152

542

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

3.2

31.9

132

435

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

3.5

31.5

113

340

XPX04

NOMESCO Finland

Angioscopy

54.2

31.4

UJF30

NOMESCO Finland

Ileoscopy through colon

2.5

30.2

205

881

R4110

NOMESCO Finland

Physiotherapy

2.0

30.2

459

2738

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

3.7

30.0

100

287

TK800

NOMESCO Finland

Hemodialysis

6.7

29.5

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

4.6

29.4

160

TND11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in joint, wrist or hand

6.9

29.4

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

2.3

29.4

247

1169

C08CA02

ATC

felodipine; oral

2.8

29.4

158

604

GD1AD

NOMESCO Finland

Thorax CT examination

3.2

29.3

122

403

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

3.7

29.1

273

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

3.3

29.1

113

358

B01AB05

ATC

enoxaparin; parenteral

1.9

28.9

508

3173

Z3231

NOMESCO Finland

Registered nurse

2.0

28.7

433

2568

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

2.9

28.7

148

553

R06.0

ICD-10 Finland

Dyspnoea

2.0

28.5

448

2694

L93.2

ICD-10 Finland

Other local lupus erythematosus

+∞

28.2

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

3.5

27.9

102

311

M35.8

ICD-10 Finland

Other specified systemic involvement of connective tissue

286.9

27.8

Z2221

NOMESCO Finland

Medical doctor

1.9

27.7

456

2780

137

Kela drug reimbursment

Uraemia requiring dialysis

11.4

27.6

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

4.6

27.6

152

NF1AA

NOMESCO Finland

Hip X-ray examination

2.6

27.1

167

683

NH3EA

NOMESCO Finland

Feet X-ray examination with load

5.1

27.1

118

XW000

NOMESCO Finland

Bone marrow biopsy

3.8

27.0

234

D70.89

ICD-10 Finland

Neutropenic splenomegaly

6.7

26.9

M79.7

ICD-10 Finland

Fibromyalgia

3.6

26.8

269

A02BC01

ATC

omeprazole; systemic

1.9

26.8

439

2667

E000001, ,

ATC

2.0

26.4

337

1876

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.8

26.2

654

4527

A46

ICD-10 Finland

Erysipelas

2.3

26.1

226

1080

WZA10

NOMESCO Finland

Extensive medical or dental certificate

6.2

26.0

A07EC01

ATC

sulfasalazine; oral, rectal

2.7

25.8

154

620

J05AB11

ATC

valaciclovir; oral

2.1

25.6

276

1440

UGC12

NOMESCO Finland

Flexible bronchoscopy

2.9

25.3

127

467

D64.9

ICD-10 Finland

Anaemia, unspecified

2.5

25.3

168

713

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

2.2

25.2

243

1213

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

2.0

25.2

319

1767

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

4.0

25.1

190

N08.5*M31.3

ICD-10 Finland

Glomerular disorders in Wegener's granulomatosis

+∞

25.1

J01FA06

ATC

roxithromycin; oral

1.8

25.0

637

4419

S81.8

ICD-10 Finland

Open wound of other parts of lower leg

4.1

25.0

173

313

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)

3.9

24.8

196

Z3229

NOMESCO Finland

Other healthcare associate professional

2.7

24.8

146

583

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

3.3

24.8

298

L27.0

ICD-10 Finland

Generalized skin eruption due to drugs and medicaments

5.9

24.6

R70.0

ICD-10 Finland

Elevated erythrocyte sedimentation rate

5.1

24.5

105

TNX00

NOMESCO Finland

Puncture and needle biopsy of soft tissue, unspecified region

4.9

24.5

113

A02BC03

ATC

lansoprazole; oral

1.9

24.4

458

2891

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

2.6

24.4

159

668

Z3226

NOMESCO Finland

Physiotherapist

2.0

24.4

302

1658

L01AA01

ATC

cyclophosphamide; systemic

29.7

24.1

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.7

23.7

132

513

L28

ICPC

Limited function/disability (L)

2.0

23.6

307

1713

M81.9

ICD-10 Finland

Osteoporosis, unspecified

3.1

23.5

105

361

TNH11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in ankle joint or foot joint

6.6

23.5

XCW99

NOMESCO Finland

Other investigative procedure of eye

2.4

23.1

181

827

M34.1

ICD-10 Finland

CR(E)ST syndrome

+∞

23.0

A07AA02

ATC

nystatin; oral

2.8

22.9

117

434

A12AA04

ATC

calcium carbonate; oral

6.5

22.7

J05AB01

ATC

aciclovir; systemic

1.9

22.7

392

2402

XQ848

NOMESCO Finland

Dermatological photography

3.9

22.7

181

D07AC13

ATC

mometasone; topical

1.8

22.7

457

2937

L98.9

ICD-10 Finland

Disorder of skin and subcutaneous tissue, unspecified

5.4

22.4

N18.8

ICD-10 Finland

Other chronic renal failure

5.3

22.3

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

2.5

22.3

146

614

D07AD01

ATC

clobetasol; topical

2.0

22.2

290

1617

C08CA01

ATC

amlodipine; oral

1.8

22.2

543

3688

M31.3

ICD-10 Finland

Wegener granulomatosis

+∞

21.9

73491

ICD-8 Finland

Diffuse diseases of connective tissue, Collagenosis NUD

+∞

21.9

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

3.7

21.9

195

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.0

21.8

256

1374

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.4

21.7

163

730

R21

ICD-10 Finland

Rash and other nonspecific skin eruption

2.9

21.6

104

373

NH3BA

NOMESCO Finland

Foot and toes extensive X-ray examination

3.3

21.6

271

D07AB02

ATC

hydrocortisone butyrate; topical

1.8

21.6

475

3124

B03XA02

ATC

darbepoetin alfa; parenteral

4.8

21.4

102

TGC00

NOMESCO Finland

Bronchial lavation

4.3

21.0

128

M31.5

ICD-10 Finland

Giant cell arteritis with polymyalgia rheumatica

61.0

20.9

B99

ICD-10 Finland

Other and unspecified infectious diseases

4.9

20.9

M34.0

ICD-10 Finland

Progressive systemic sclerosis

+∞

20.9

WW200

NOMESCO Finland

Immunization

4.2

20.7

138

J01DB01

ATC

cefalexin; oral

2.0

20.6

1220

10541

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

2.1

20.5

208

1054

N03AX16

ATC

[U] pregabalin

1.8

20.5

359

2198

ZX108

NOMESCO Finland

Inhalation

17.2

20.5

J84.9

ICD-10 Finland

Interstitial pulmonary disease, unspecified

5.0

20.5

A01

ICPC

Pain general/multiple sites

2.2

20.4

188

918

281

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab

3.7

20.3

186

R59.0

ICD-10 Finland

Localized enlarged lymph nodes

3.4

20.3

220

M35.7

ICD-10 Finland

Hypermobility syndrome

19.1

20.0

L95

ICPC

Osteoporosis

3.0

20.0

322

NH1AE

NOMESCO Finland

Ankle joint ultrasound examination

7.4

20.0

M25.5

ICD-10 Finland

Pain in joint

1.7

19.9

549

3826

7109X

ICD-9 Finland

Diffuse diseases of connective tissue, Unspecified diffuse connective tissue disease

+∞

19.8

N16.4*M32.1

ICD-10 Finland

Renal tubulo-interstitial disorders in systemic lupus erythematosus

+∞

19.8

I32.8*M32.1

ICD-10 Finland

Pericarditis (in) systemic lupus erythematosus

+∞

19.8

UJF32

NOMESCO Finland

Coloscopy

1.8

19.8

386

2439

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

2.4

19.8

147

655

SPAT1148

SPAT

Treatment of chronic ulcer or burn

2.2

19.7

191

951

ND2BA

NOMESCO Finland

Hand and fingers extensive X-ray examination

3.9

19.6

153

I50.9

ICD-10 Finland

Heart failure, unspecified

2.2

19.6

172

823

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

5.1

19.6

L84

ICD-10 Finland

Corns and callosities

3.3

19.5

231

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

4.1

19.4

136

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

2.4

19.4

140

615

M05BA06

ATC

ibandronic acid; systemic

4.0

19.3

141

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.7

19.3

579

4120

JN4AD

NOMESCO Finland

Body CT examination

2.2

19.3

174

842

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

2.8

19.2

363

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

2.8

19.1

364

N08.5*M31.1

ICD-10 Finland

Glomerular disorders in thrombotic thrombocytopenic purpura

+∞

18.8

Z2446

NOMESCO Finland

Social worker

2.5

18.8

119

492

TNG10

NOMESCO Finland

Puncture of knee

5.4

18.8

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

2.2

18.8

166

796

L04AD02

ATC

tacrolimus; systemic

7.1

18.7

J01MA14

ATC

moxifloxacin; systemic

2.3

18.6

148

679

PAW37

NOMESCO Finland

Biopsy of temporal artery

38.9

18.6

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

2.3

18.5

158

746

M01AH02

ATC

rofecoxib; oral

2.1

18.5

198

1023

J01DA01

ATC

[U] cefalexin

1.7

18.5

911

7321

TAB00

NOMESCO Finland

Lumbar puncture

2.9

18.3

332

J84.1

ICD-10 Finland

Other interstitial pulmonary diseases with fibrosis

5.4

18.3

M06.0

ICD-10 Finland

Seronegative rheumatoid arthritis

3.5

18.1

186

R07.4

ICD-10 Finland

Chest pain, unspecified

1.7

18.1

421

2788

AA1AD

NOMESCO Finland

CT of head and brain

1.7

18.0

408

2680

A02BC05

ATC

esomeprazole; systemic

1.6

18.0

617

4519

N03AX12

ATC

[U] gabapentin; oral

1.9

18.0

258

1477

C02CA01

ATC

prazosin; oral

6.8

17.9

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

2.1

17.9

185

943

WZC00

NOMESCO Finland

Treatment plan or consultation

1.6

17.8

563

4037

M31.1

ICD-10 Finland

Thrombotic microangiopathy

+∞

17.7

N32.9

ICD-10 Finland

Bladder disorder, unspecified

14.8

17.6

C07AB07

ATC

bisoprolol; oral

1.6

17.4

650

4849

N17.9

ICD-10 Finland

Acute renal failure, unspecified

3.3

17.4

206

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

5.7

17.3

CK2S4

NOMESCO Finland

Plain photography of ocular fundus

2.5

17.3

111

462

N06AA09

ATC

amitriptyline; systemic

2.1

17.2

166

823

N02AA05

ATC

oxycodone; systemic

1.9

17.2

258

1497

J02AC01

ATC

fluconazole; systemic

1.6

17.1

668

5031

QC6S1

NOMESCO Finland

Photography of skin or subcutaneous tissue in hand

50.6

17.0

3AC01, ,

NOMESCO Finland

6.9

17.0

71239

ICD-8 Finland

Rheumatoid arthritis and allied conditions, Arthritis rheumatoides NUD

7.6

17.0

SAA03

NOMESCO Finland

Extended examination of mouth

1.6

16.9

601

4420

TQW80

NOMESCO Finland

Local dermatologic skincare

3.8

16.8

137

B02.9

ICD-10 Finland

Zoster without complication

2.4

16.7

124

551

EP1AE

NOMESCO Finland

Neck ultrasound examination

2.5

16.7

110

463

H02AB09

ATC

hydrocortisone; systemic

3.8

16.7

138

M31.9

ICD-10 Finland

Necrotizing vasculopathy, unspecified

171.9

16.5

H05AA02

ATC

teriparatide; parenteral

13.6

16.5

A02BA02

ATC

ranitidine; systemic

1.8

16.3

283

1716

S97

ICPC

Chronic ulcer skin

2.6

16.3

100

407

C02DE02, ,

ATC

6.9

16.2

R87.6

ICD-10 Finland

Abnormal findings in specimens from female genital organs, abnormal cytological findings

2.0

16.1

185

980

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

3.0

16.1

243

6BA02, ,

NOMESCO Finland

24.8

16.0

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

3.0

15.9

255

KA2AE

NOMESCO Finland

Ultrasound examination transplanted kidney

14.7

15.9

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

3.3

15.9

187

K07.65

ICD-10 Finland

Temporomandibular joint-pain-dysfunction syndrome

5.3

15.8

J01AA02

ATC

doxycycline; systemic

1.7

15.8

1130

9771

K90.0

ICD-10 Finland

Coeliac disease

3.2

15.7

198

A01AC01

ATC

triamcinolone; local oral

5.0

15.7

NA1EA

NOMESCO Finland

Cervical spine X-ray examination with flexion

4.8

15.7

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.8

15.7

258

1538

M31.8

ICD-10 Finland

Other specified necrotizing vasculopathies

+∞

15.6

F02.89*M32.8

ICD-10 Finland

Dementia in systemic lupus erythematosus

+∞

15.6

WX002

NOMESCO Finland

Sedation and analgesia

1.8

15.6

279

1705

Z49.0

ICD-10 Finland

Preparatory care for dialysis

11.9

15.6

XG470

NOMESCO Finland

Measurement of diffusion capastity of the lungs

3.7

15.6

140

69540

ICD-8 Finland

Erythematous condition, Lupus erythematosus

161.7

15.5

WZC05

NOMESCO Finland

Specialty-specific consultation based on referral by dentist or doctor

2.7

15.5

345

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.8

15.4

279

1710

TEA00

NOMESCO Finland

Biopsy of lip

6.5

15.4

D02AX

ATC

Other emollients and protectives

3.2

15.3

196

I31.9

ICD-10 Finland

Disease of pericardium, unspecified

11.4

15.3

KA2AT

NOMESCO Finland

Biopsy of transplanted kidney with ultrasound guidance

16.2

15.3

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

2.7

15.2

319

WX203

NOMESCO Finland

Infraclavicular plexus blockade

3.7

15.2

133

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.9

15.0

219

1256

N02AC04

ATC

dextropropoxyphene; oral

3.2

14.9

189

L04AB01

ATC

etanercept; parenteral

4.3

14.8

ZX140

NOMESCO Finland

Intra articular

6.0

14.8

D02BB01

ATC

betacarotene; oral

21.3

14.7

JN3AD

NOMESCO Finland

Abdominal CT examination

1.9

14.6

192

1063

M33.9

ICD-10 Finland

Dermatopolymyositis, unspecified

+∞

14.6

M05BA01

ATC

etidronic acid; systemic

12.0

14.6

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

2.4

14.6

100

429

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

3.6

14.6

132

M02.9

ICD-10 Finland

Reactive arthropathy, unspecified

4.4

14.6

R51.80

ICD-10 Finland

Headache

1.8

14.5

269

1658

L93

ICD-10 Finland

Lupus erythematosus

151.5

14.5

G73.7

ICD-10 Finland

Myopathy in other diseases classified elsewhere

151.5

14.5

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

2.1

14.4

152

780

I30.9

ICD-10 Finland

Acute pericarditis, unspecified

11.5

14.3

M01CB01

ATC

sodium aurothiomalate; parenteral

4.8

14.3

M05.9

ICD-10 Finland

Seropositive rheumatoid arthritis, unspecified

3.5

14.2

139

ZXX01

NOMESCO Finland

Extent of proceudre, 1 unit

6.2

14.2

JN4BD

NOMESCO Finland

Extensive body CT

2.1

14.2

142

714

ULA02

NOMESCO Finland

Kolposcopy

1.9

14.0

180

988

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

2.1

14.0

133

654

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

3.4

14.0

155

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

4.0

14.0

103

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.9

14.0

207

1192

ZXE10

NOMESCO Finland

More than one and less than three hours

1.6

13.9

497

3618

M81.4

ICD-10 Finland

Drug-induced osteoporosis

12.8

13.9

L01BB01, ,

ATC

30.3

13.9

A12BA01

ATC

potassium chloride; oral

2.9

13.7

237

Z49.2

ICD-10 Finland

Other dialysis

12.2

13.6

XQ841

NOMESCO Finland

Examination of dermatosis with microscope

75.9

13.6

WX892

NOMESCO Finland

Monitored bed care

2.3

13.6

107

488

N08.5*M31.7

ICD-10 Finland

Glomerular disease states in microscopic polyangiitis

+∞

13.6

7108X

ICD-9 Finland

Diffuse diseases of connective tissue, Other specified diffuse diseases of connective tissue

+∞

13.6

C02KX01

ATC

bosentan; oral

+∞

13.6

SPAT1149

SPAT

Suture or treatment of traumatic wound

2.0

13.5

164

883

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.5

13.5

627

4827

D07AA02

ATC

hydrocortisone; topical

1.8

13.5

214

1258

G73.7*M35.0

ICD-10 Finland

Myopathy in sicca syndrome [Sjögren]

141.3

13.5

M34.8

ICD-10 Finland

Other forms of systemic sclerosis

141.3

13.5

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.0

13.5

151

791

H19.3*M35.0

ICD-10 Finland

Keratoconjunctivitis sicca

26.0

13.4

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.6

13.3

445

3183

A41.9

ICD-10 Finland

Sepsis, unspecified

3.1

13.3

181

ZXA05

NOMESCO Finland

Left side

1.7

13.3

329

2189

N02BE01

ATC

paracetamol; systemic, rectal

2.0

13.3

1296

11821

B05DA

ATC

Isotonic solutions

10.6

13.3

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.9

13.2

171

942

B05DB

ATC

Hypertonic solutions

12.3

13.1

M13.0

ICD-10 Finland

Polyarthritis, unspecified

4.8

13.1

R06AE07

ATC

cetirizine; oral

1.5

13.1

668

5237

A01AB10

ATC

natamycin; local oral

3.1

13.1

178

A63.0

ICD-10 Finland

Anogenital (venereal) warts

2.7

13.0

256

D80.1

ICD-10 Finland

Nonfamilial hypogammaglobulinaemia

19.2

12.9

C09AA02

ATC

enalapril; systemic

1.7

12.9

242

1493

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

2.9

12.8

218

NB1AE

NOMESCO Finland

Shoulder ultrasound examination

3.7

12.8

110

XCK00

NOMESCO Finland

Perimetry

2.4

12.8

397

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

2.0

12.8

143

748

B01AB04

ATC

dalteparin; parenteral

2.5

12.8

335

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

2.1

12.8

120

588

NH1CG

NOMESCO Finland

Ankle and foot extensive MRI examination with high intensity magnet

4.3

12.7

XF404

NOMESCO Finland

Ambulatory ECG

2.1

12.6

120

591

C03DA01

ATC

spironolactone; oral

1.9

12.6

163

897

N04.9

ICD-10 Finland

Nephrotic syndrome, unspecified

32.3

12.6

GA1AE

NOMESCO Finland

Ultrasound examination of thorax

3.5

12.6

121

XF655

NOMESCO Finland

Measurement of heart muscle perfusion with exercise

3.5

12.6

121

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.7

12.6

258

1632

M33.2

ICD-10 Finland

Polymyositis

131.1

12.5

7140A

ICD-9 Finland

Rheumatoid arthritis and other inflammatory polyarthropathies, Rheumatoid arthritis[ARTHRITIS RHEUMATOIDES SEROPOSITIVA]

5.1

12.4

I80.3

ICD-10 Finland

Phlebitis and thrombophlebitis of lower extremities, unspecified

2.7

12.4

250

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.7

12.4

256

1620

XF600

NOMESCO Finland

Bloodpressure measurement

2.3

12.4

415

205

Kela drug reimbursment

Chronic hypertension

1.6

12.4

310

2063

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

2.7

12.4

262

J01MA06

ATC

norfloxacin; oral

1.8

12.4

208

1243

NA2BG

NOMESCO Finland

Thoracal spine MRI examination with high intensity magnet

3.1

12.3

163

R80

ICD-10 Finland

Isolated proteinuria

9.7

12.2

SHA02

NOMESCO Finland

Stomatognathic treatment, basic

2.0

12.2

131

675

ZXA00

NOMESCO Finland

Right side

1.6

12.2

355

2452

B37.09

ICD-10 Finland

Unspecified candidal stomatitis

5.0

12.2

A01AB09

ATC

miconazole; local oral

2.0

12.2

134

697

P01AB01

ATC

metronidazole; oral, rectal

1.5

12.2

611

4752

NH3AE

NOMESCO Finland

Feet ultrasound examination

12.5

12.1

H53.1

ICD-10 Finland

Subjective visual disturbances

2.1

12.1

115

566

L50.9

ICD-10 Finland

Urticaria, unspecified

2.6

12.1

295

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

2.2

12.1

103

486

I83.0

ICD-10 Finland

Varicose veins of lower extremities with ulcer

3.6

12.0

110

H20.1

ICD-10 Finland

Chronic iridocyclitis

5.3

12.0

XG410

NOMESCO Finland

Flow-volume spirometry

2.8

12.0

226

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

9.4

12.0

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

2.9

11.9

193

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

2.6

11.9

279

SPAT1263

SPAT

Sampling

1.5

11.8

577

4456

M84.3

ICD-10 Finland

Stress fracture, not elsewhere classified

4.0

11.8

D02AE01

ATC

carbamide; topical

2.2

11.7

101

478

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

2.5

11.7

324

R59.1

ICD-10 Finland

Generalized enlarged lymph nodes

4.4

11.7

XA800

NOMESCO Finland

Neuropsychological investigation

2.5

11.7

294

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.5

11.7

432

3145

WX408

NOMESCO Finland

General anesthesy, balanced

1.6

11.7

343

2371

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.7

11.6

223

1382

WW400

NOMESCO Finland

Plasmaferesis

65.5

11.6

I35.1

ICD-10 Finland

Aortic (valve) insufficiency

2.6

11.6

271

R05

ICD-10 Finland

Cough

1.6

11.6

323

2204

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

2.8

11.6

202

S01XA18

ATC

ciclosporin; ophthalmic

5.3

11.6

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

2.2

11.5

468

S76

ICPC

Skin infection other

2.3

11.5

390

N30.0

ICD-10 Finland

Acute cystitis

1.6

11.5

288

1915

N08.5*M30.0

ICD-10 Finland

Glomerular disorders in polyarteritis nodosa

+∞

11.5

J99.1

ICD-10 Finland

Respiratory disorders in other diffuse connective tissue disorders

+∞

11.5

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.5

11.5

309

K75.9

ICD-10 Finland

Inflammatory liver disease, unspecified

4.9

11.5

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

2.0

11.4

131

692

K11.2

ICD-10 Finland

Sialoadenitis

2.7

11.4

221

R52.9

ICD-10 Finland

Pain, unspecified

1.9

11.4

155

867

JN6DR

NOMESCO Finland

PET-CT of whole body metabolism

5.4

11.4

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

2.3

11.3

367

ZXE00

NOMESCO Finland

One hour or less

1.5

11.3

540

4141

NH3FA

NOMESCO Finland

Weight-bearing X-ray of foot

3.3

11.3

135

NE1AA

NOMESCO Finland

Pelvis X-ray examination

2.1

11.3

112

561

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

3.0

11.3

172

D01AE16

ATC

amorolfine; topical

1.8

11.3

166

952

ZXE20

NOMESCO Finland

More than three and less than five hours

1.8

11.2

175

1021

Z35.8

ICD-10 Finland

Supervision of other high-risk pregnancies

2.0

11.2

133

711

K07.60

ICD-10 Finland

Snapping jaw

2.2

11.1

468

M01AE03

ATC

ketoprofen; systemic, rectal

1.5

11.1

495

3737

R13

ICD-10 Finland

Dysphagia

2.1

11.1

110

550

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

2.8

11.1

201

I82.88

ICD-10 Finland

Embolism and thrombosis of other specified veins

3.7

11.1

NDL52

NOMESCO Finland

Tenosynovectomy of hand

5.3

11.1

A01AB04

ATC

amphotericin B; local oral

2.4

11.0

327

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

1.9

11.0

153

861

XLD00

NOMESCO Finland

Sytologyspecimen from mouth of uterus

1.7

11.0

205

1260

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.7

11.0

225

1419

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.6

11.0

287

1927

S01KA02

ATC

hypromellose; ophthalmic

3.6

10.9

103

R03AC02

ATC

salbutamol; inhalant

1.5

10.9

809

6737

I34.09

ICD-10 Finland

Mitral (valve) insufficiency

2.6

10.8

233

R4190

NOMESCO Finland

Nutritional therapy

2.5

10.8

269

D07BA04

ATC

hydrocortisone and antiseptics; topical

1.9

10.6

139

767

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

2.3

10.6

352

H20.0

ICD-10 Finland

Acute and subacute iridocyclitis

2.5

10.5

272

NG1AE

NOMESCO Finland

Knee joint ultrasound exmination

4.0

10.5

S01AA01

ATC

chloramphenicol; ophthalmic

2.3

10.5

348

M35.2

ICD-10 Finland

Behçet disease

+∞

10.4

M33.1

ICD-10 Finland

Other dermatomyositis

+∞

10.4

M01AH01

ATC

celecoxib; oral

1.6

10.4

250

1641

L17

ICPC

Foot/toe symptom/complaint

1.5

10.4

446

3333

R1250

NOMESCO Finland

Evaluation of functional capability

3.0

10.4

158

E000007, ,

ATC

2.2

10.4

434

UKC02

NOMESCO Finland

Cystoscopy

1.8

10.4

167

983

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.8

10.4

172

1022

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.5

10.3

395

2883

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

3.3

10.3

122

M46.9

ICD-10 Finland

Inflammatory spondylopathy, unspecified

4.4

10.3

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.9

10.3

135

746

E000006, ,

ATC

2.0

10.2

107

546

XFE00

NOMESCO Finland

Epicardial ultrasonography

3.5

10.2

R76.0

ICD-10 Finland

Raised antibody titre

13.2

10.2

V03AE02

ATC

sevelamer; oral

13.2

10.2

N03AF02

ATC

oxcarbazepine; oral

2.7

10.2

211

NHG76

NOMESCO Finland

Arthroplasty of other tarsometatarsal joint

3.9

10.1

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.7

10.1

203

1271

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.7

10.1

194

1202

D68.9

ICD-10 Finland

Coagulation defect, unspecified

11.4

10.1

EB1CI

NOMESCO Finland

Cone beam imaging of teeth and jaws (3-4 quarters)

5.1

10.1

QAA25

NOMESCO Finland

Destruction of lesion of head or neck

3.3

10.0

114

Z50.1

ICD-10 Finland

Other physical therapy

2.2

10.0

374

L71.9

ICD-10 Finland

Rosacea, unspecified

2.8

10.0

184

R42

ICD-10 Finland

Dizziness and giddiness

1.5

9.9

317

2226

ZXD05

NOMESCO Finland

Urgent procedure

1.5

9.9

404

2986

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

2.0

9.8

114

604

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

2.1

9.8

444

UJD02

NOMESCO Finland

Gastroscopy

2.4

9.8

300

A12AA12

ATC

[U] calcium acetate

26.2

9.8

K13.79

ICD-10 Finland

Change in the oral mucosa UNS

2.6

9.8

209

R04.0

ICD-10 Finland

Epistaxis

2.0

9.8

100

506

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.4

9.8

749

6221

SHA03

NOMESCO Finland

Stomatognathic treatment, demanding

2.5

9.8

251

K99

ICPC

Cardiovascular disease other

3.2

9.8

116

H10.0

ICD-10 Finland

Mucopurulent conjunctivitis

1.9

9.8

121

656

H05BA01

ATC

calcitonin (salmon synthetic); nasal, parenteral

2.8

9.7

181

G40.9

ICD-10 Finland

Epilepsy, unspecified

2.6

9.7

210

R23.3

ICD-10 Finland

Spontaneous ecchymoses

3.1

9.7

132

A02BA04

ATC

nizatidine; systemic

2.0

9.7

103

529

N05CF01

ATC

zopiclone; oral

1.5

9.6

437

3294

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.1

9.6

475

R4180

NOMESCO Finland

Podiatric therapy

4.3

9.6

A07AA09

ATC

vancomycin; oral

4.3

9.6

SPAT1229

SPAT

Assessment of need for aid

2.0

9.6

103

531

C07AB02

ATC

metoprolol; systemic

1.6

9.5

247

1651

Z96.1

ICD-10 Finland

Presence of intraocular lens

1.7

9.5

183

1134

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

2.3

9.5

337

SBA00

NOMESCO Finland

Microbiological examinations

2.8

9.4

167

S01BA04

ATC

prednisolone; ophthalmic

3.1

9.4

129

FB1AD

NOMESCO Finland

CT examination of arteria pulmonalis

2.8

9.4

162

M31.7

ICD-10 Finland

Microscopic polyangiitis

+∞

9.4

58199

ICD-8 Finland

Nephrotic syndrome

+∞

9.4

H15.1

ICD-10 Finland

Episcleritis

3.5

9.4

D72.8

ICD-10 Finland

Other specified disorders of white blood cells

5.2

9.4

R2120

NOMESCO Finland

Counselling and guidance concerning rehabilitation services and social security

5.2

9.4

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.7

9.4

199

1265

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

3.4

9.3

E78.0

ICD-10 Finland

Pure hypercholesterolaemia

0.6

9.3

138

2277

T78.4

ICD-10 Finland

Allergy, unspecified

2.2

9.3

366

R81

ICPC

Pneumonia

2.5

9.3

245

LCA06

NOMESCO Finland

Biopsy of endometrium

1.6

9.3

208

1340

TPX10

NOMESCO Finland

Implantation of vascular injection port

2.7

9.3

180

N12

ICD-10 Finland

Tubulo-interstitial nephritis, not specified as acute or chronic

4.1

9.3

QAA05

NOMESCO Finland

Incision for biopsy of skin of head or neck

3.1

9.3

120

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

2.8

9.2

169

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.6

9.2

213

1383

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

2.1

9.2

428

N02AJ06

ATC

codeine and paracetamol; systemic

1.4

9.2

596

4790

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.4

9.2

732

6097

N03AX14

ATC

levetiracetam; systemic

2.8

9.1

170

TNG11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in knee

4.3

9.1

TFC00

NOMESCO Finland

Catheterisation of right atrium or ventricle

4.3

9.1

J01EA01

ATC

trimethoprim; systemic

1.5

9.1

397

2963

M01AE02

ATC

naproxen; oral, rectal

1.4

9.1

806

6830

A04

ICPC

Weakness/tiredness general

1.6

9.1

231

1534

K73.2

ICD-10 Finland

Chronic active hepatitis, not elsewhere classified

11.5

9.1

E000002, ,

ATC

1.7

9.1

157

944

Z2445

NOMESCO Finland

Psychologist

2.5

9.1

242

5BA08, ,

NOMESCO Finland

9.1

9.0

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

2.1

9.0

404

PJA10

NOMESCO Finland

Exploration of lymph nodes

4.1

9.0

J94.8

ICD-10 Finland

Other specified pleural conditions

4.1

9.0

A03FA01

ATC

metoclopramide; systemic, rectal

1.5

9.0

327

2354

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

1.9

8.9

113

617

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

2.5

8.9

232

TK810

NOMESCO Finland

Hemofiltration

12.6

8.9

N03.9

ICD-10 Finland

Chronic nephritic syndrome, unspecified

12.6

8.9

SAA04

NOMESCO Finland

Special examination of mouth

2.1

8.8

387

B37.08

ICD-10 Finland

Other candidal stomatitis

4.7

8.8

K65.0

ICD-10 Finland

Acute peritonitis

4.7

8.8

D06BB10

ATC

imiquimod; topical

2.1

8.7

382

UJF92

NOMESCO Finland

Capsular endoscopy

3.1

8.7

119

NDB78

NOMESCO Finland

Prosthetic replacement of several of finger or metacarpal

14.1

8.7

M35

ICD-10 Finland

Other systemic involvement of connective tissue

50.3

8.7

NHG80

NOMESCO Finland

Fusion of first tarsometatarsal joint

2.3

8.7

272

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.7

8.7

155

940

NA1BA

NOMESCO Finland

Cervical spine extensive X-ray examination without contrast

6.6

8.7

WX110

NOMESCO Finland

Infiltration anesthesia

1.4

8.7

1014

8984

C01DA14

ATC

isosorbide mononitrate; oral

1.7

8.6

155

941

EBA10

NOMESCO Finland

Operative extraction of tooth

1.7

8.6

176

1106

H26.2

ICD-10 Finland

Complicated cataract

3.8

8.6

SPAT1325

SPAT

Vaccination

1.4

8.6

419

3190

H20.9

ICD-10 Finland

Iridocyclitis, unspecified

3.8

8.5

K76.9

ICD-10 Finland

Liver disease, unspecified

3.8

8.5

G04BE03

ATC

sildenafil; oral

6.4

8.5

B34.9

ICD-10 Finland

Viral infection, unspecified

2.7

8.5

177

R02

ICPC

Shortness of breath/dyspnoea

1.6

8.5

188

1207

H57.1

ICD-10 Finland

Ocular pain

2.2

8.5

307

M79.6

ICD-10 Finland

Pain in limb

1.4

8.5

638

5237

TNE25

NOMESCO Finland

Drill biopsy of bone marrow, pelvis

4.2

8.5

ZX100

NOMESCO Finland

Oral

3.7

8.5

S32.0

ICD-10 Finland

Fracture of lumbar vertebra

2.5

8.5

213

EB1WA, ,

NOMESCO Finland

7.4

8.5

A28

ICPC

Limited function/disability NOS

1.6

8.4

217

1445

S01GX01

ATC

cromoglicic acid; ophthalmic

1.5

8.4

309

2225

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

1.9

8.4

115

644

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

2.1

8.4

395

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.6

8.4

193

1252

286

Kela drug reimbursment

Ciclosporin eye drop

+∞

8.3

M31.0

ICD-10 Finland

Hypersensitivity angiitis

+∞

8.3

7100A, ,

ICD-10 Finland

+∞

8.3

4430A

ICD-9 Finland

Other peripheral vascular disease, Raynaud's syndrome

+∞

8.3

4AA26, ,

NOMESCO Finland

+∞

8.3

J99.1*M31.3

ICD-10 Finland

Respiratory disorders in Wegener's granulomatosis

+∞

8.3

TQW40

NOMESCO Finland

Remowal of suture of skin

1.9

8.3

102

551

N30.9

ICD-10 Finland

Cystitis, unspecified

1.9

8.3

106

580

J01MA01

ATC

ofloxacin; systemic

1.9

8.3

104

566

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

1.8

8.3

132

774

M01AX01

ATC

nabumetone; oral

2.3

8.3

265

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

2.0

8.3

502

R60.0

ICD-10 Finland

Localized oedema

1.7

8.3

167

1047

WW500

NOMESCO Finland

Blood transfusion

2.3

8.3

259

A40.3

ICD-10 Finland

Sepsis due to Streptococcus pneumoniae

7.1

8.3

182

Kela drug reimbursment

Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide

2.9

8.3

134

ZXD10

NOMESCO Finland

Scheduled procedure

1.4

8.2

495

3906

M01AB55

ATC

diclofenac, combinations; oral

2.0

8.2

496

K29.3

ICD-10 Finland

Chronic superficial gastritis

2.6

8.2

186

LDA20

NOMESCO Finland

Biopsy of vaginal cervix

1.9

8.2

110

612

N87.1

ICD-10 Finland

Moderate cervical dysplasia

2.7

8.2

163

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.4

8.2

525

4190

NK5AT

NOMESCO Finland

Joint injection with ultrasound guidance not elsewhere classified

4.4

8.2

TKC20

NOMESCO Finland

Catheterisation of bladder

2.1

8.1

386

ZXX02

NOMESCO Finland

Extent of procedure, 2 units

3.6

8.1

71238

ICD-8 Finland

Rheumatoid arthritis and allied conditions, Arthritis rheumatoides alia definita

4.8

8.1

NG1EA

NOMESCO Finland

Knee X-ray examination with wrench

3.4

8.1

LFB10

NOMESCO Finland

Excision of lesion of vulva or perineum

3.8

8.1

KA9AE

NOMESCO Finland

Ultrasound examination transplanted kidney

11.8

8.1

RT271, ,

NOMESCO Finland

17.3

8.1

PJ2AE

NOMESCO Finland

Lymphnode ultrasound examination

6.9

8.1

G40.22

ICD-10 Finland

Complex partial epileptic seizure with secondary generalization

3.0

8.1

114

M80.9

ICD-10 Finland

Unspecified osteoporosis with pathological fracture

2.9

8.0

125

RJ421, ,

NOMESCO Finland

10.1

8.0

PF1AT

NOMESCO Finland

Intravascular dilatation of arteries of knee, lower leg and ankle (PTA)

10.1

8.0

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.5

8.0

301

2177

J10.1

ICD-10 Finland

Influenza with other respiratory manifestations, seasonal influenza virus identified

3.5

8.0

N06AB04

ATC

citalopram; systemic

1.5

7.9

288

2066

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

6.6

7.9

NB1BA

NOMESCO Finland

Shoulder extensive X-ray examination without contrast

2.5

7.9

208

G03.9

ICD-10 Finland

Meningitis, unspecified

13.1

7.9

RT274, ,

NOMESCO Finland

13.1

7.9

R68.2

ICD-10 Finland

Dry mouth, unspecified

7.8

7.9

SPAT1254

SPAT

Administration of medicine

1.6

7.9

182

1181

C07AG02

ATC

carvedilol; oral

2.1

7.9

371

SHB00

NOMESCO Finland

Preparing and fitting the occlusal splint in the mouth

1.6

7.8

167

1061

D06BX01

ATC

metronidazole; topical

1.6

7.8

166

1054

M19.2

ICD-10 Finland

Other secondary arthrosis

3.8

7.8

X58

ICD-10 Finland

Exposure to other specified factors

1.6

7.8

201

1338

RT272, ,

NOMESCO Finland

9.5

7.8

TK820

NOMESCO Finland

Peritoneal dialysis

9.5

7.8

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.4

7.8

370

2796

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

2.6

7.7

168

L94.9

ICD-10 Finland

Localized connective tissue disorder, unspecified

45.2

7.7

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

2.7

7.7

145

ZZA00

NOMESCO Finland

Split skin graft

2.8

7.7

134

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.6

7.7

209

1409

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

1.9

7.7

537

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

2.1

7.7

354

X59

ICD-10 Finland

Exposure to unspecified factor

1.5

7.7

250

1754

K92

ICPC

Atherosclerosis/periph vascular dis

4.5

7.7

D20

ICPC

Mouth/tongue/lip symptom/complaint

2.1

7.7

361

S29

ICPC

Skin symptom/complaint other

1.5

7.6

282

2029

L71.8

ICD-10 Finland

Other rosacea

2.9

7.6

118

ZXA10

NOMESCO Finland

Bilateral

1.5

7.6

234

1621

L94.8

ICD-10 Finland

Other specified localized connective tissue disorders

25.1

7.6

TQW99

NOMESCO Finland

Other minor procedure on skin

2.1

7.6

322

SPAT1255

SPAT

Intravenous administration of medicine

2.0

7.6

425

LEB00

NOMESCO Finland

Biopsy of vagina

2.9

7.6

124

QDG20

NOMESCO Finland

Operation for chronic ulcer or fistula of skin of lower limb

6.2

7.5

WX204

NOMESCO Finland

Axillary plexus blockaced

2.3

7.5

244

A03

ICPC

Fever

1.5

7.5

240

1676

L95.9

ICD-10 Finland

Vasculitis limited to skin, unspecified

7.2

7.5

NDG76

NOMESCO Finland

Fusion of DIP joint

4.4

7.4

V03AE01

ATC

polystyrene sulfonate; oral

4.4

7.4

C09AA05

ATC

ramipril; oral

1.5

7.4

278

2005

SPA00

NOMESCO Finland

Changing form of teeth in prepation for prosthodontic work

2.2

7.4

265

RD210, ,

NOMESCO Finland

3.2

7.4

C09CA01

ATC

losartan; oral

1.4

7.4

318

2356

D59.1

ICD-10 Finland

Other autoimmune haemolytic anaemias

7.7

7.4

B03XA01

ATC

erythropoietin; parenteral

6.0

7.4

D06BB04

ATC

podophyllotoxin; topical

2.0

7.4

387

QXB99

NOMESCO Finland

Other procedure to treat skin wound, unspecified location

3.0

7.4

104

R53

ICD-10 Finland

Malaise and fatigue

1.4

7.4

354

2677

C09CA06

ATC

candesartan; oral

1.4

7.3

331

2474

H26.02

ICD-10 Finland

Presenil cataract

2.6

7.3

155

B25.9

ICD-10 Finland

Cytomegaloviral disease, unspecified

10.9

7.3

N08.5*M31.0

ICD-10 Finland

Glomerular disorders in Goodpasture's syndrome

+∞

7.3

I68.2*M32.1

ICD-10 Finland

Cerebral arteritis in systemic lupus erythematosus

+∞

7.3

6954B

ICD-9 Finland

Erythematous conditions, Lupus erythematosus[LUPUS ERYTHEMATOSUS DISCOIDES DISSEMINATUS]

+∞

7.3

J45.1

ICD-10 Finland

Nonallergic asthma

1.8

7.3

100

561

TJA35

NOMESCO Finland

Removal of peritoneal dialysis catheter

9.4

7.3

ZXC12

NOMESCO Finland

Pulse colorlaser

9.4

7.3

4859X

ICD-9 Finland

Bronchopneumonia, organism unspecified[PNEUMONIA NUD]

3.2

7.3

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

2.0

7.3

410

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.4

7.3

451

3563

NHQ40

NOMESCO Finland

Amputation of toe

3.9

7.3

NHG77

NOMESCO Finland

Arthroplasty of interphalangeal tarsal joint(s)

2.7

7.3

144

I34.00

ICD-10 Finland

Mitral (valve) incompetence NOS or of specified cause, except rheumatic

3.3

7.3

L53.9

ICD-10 Finland

Erythematous condition, unspecified

3.3

7.3

QBA99

NOMESCO Finland

Other local destruction of skin of trunk

6.3

7.2

GD1CD

NOMESCO Finland

Thorax extensive CT-examination

6.3

7.2

G04.9

ICD-10 Finland

Encephalitis, myelitis and encephalomyelitis, unspecified

15.8

7.2

N25.0

ICD-10 Finland

Renal osteodystrophy

15.8

7.2

I27.9

ICD-10 Finland

Pulmonary heart disease, unspecified

15.8

7.2

H35.7

ICD-10 Finland

Separation of retinal layers

4.3

7.2

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

2.0

7.2

397

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.6

7.2

186

1238

Z71.8

ICD-10 Finland

Other specified counselling

1.4

7.2

486

3892

D69.9

ICD-10 Finland

Haemorrhagic condition, unspecified

7.3

7.2

PA2BG

NOMESCO Finland

MRI examination of vessels in the head with high intensity magnet

4.5

7.2

R50.0

ICD-10 Finland

Fever with chills

30.2

7.2

N04.0

ICD-10 Finland

Nephrotic syndrome, minor glomerular abnormality

30.2

7.2

R76.8

ICD-10 Finland

Other specified abnormal immunological findings in serum

20.1

7.1

R07.1

ICD-10 Finland

Chest pain on breathing

3.2

7.1

D06AX01

ATC

fusidic acid; topical

1.7

7.1

126

762

QDA25

NOMESCO Finland

Destruction of lesion of skin of lower limb

8.0

7.1

L20

ICPC

Joint symptom/complaint NOS

2.1

7.1

297

J01DA09

ATC

[U] cefadroxil

1.4

7.1

347

2632

D07BB04

ATC

hydrocortisone butyrate and antiseptics; topical

1.6

7.1

173

1138

6489X

ICD-9 Finland

Other current conditions in the mother classifiable elsewhere but complicating pregnancy, childbirth and the puerperium, Other current conditions classifiable elsewhere

8.8

7.1

B01AC04

ATC

clopidogrel; oral

1.6

7.0

170

1114

E86

ICD-10 Finland

Volume depletion

2.8

7.0

118

I50.1

ICD-10 Finland

Left ventricular failure

2.3

7.0

226

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

2.3

7.0

239

S18

ICPC

Laceration/cut

1.3

7.0

618

5153

R63.4

ICD-10 Finland

Abnormal weight loss

2.2

7.0

259

NE1BG

NOMESCO Finland

Pelvic, hip and femur MRI examination with high intensity magnet

2.2

7.0

246

SBB00

NOMESCO Finland

Clinical photography of mouth and teeth

2.4

7.0

208

A07EA06

ATC

budesonide; oral, local oral

2.2

6.9

253

M79.1

ICD-10 Finland

Myalgia

1.5

6.9

224

1567

L29

ICPC

Musculoskeletal sympt/complt other

1.7

6.9

127

776

TPH40

NOMESCO Finland

Insertion of a long peripheral venous catheter

5.5

6.9

320

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

7.6

6.9

RJ511, ,

NOMESCO Finland

13.8

6.9

K94

ICPC

Phlebitis/thrombophlebitis

3.1

6.9

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

1.9

6.9

433

RS221, ,

NOMESCO Finland

3.4

6.8

N05BA04

ATC

oxazepam; oral

1.4

6.8

358

2744

TNX32

NOMESCO Finland

Custom moulded splint, unspecified region

2.0

6.8

384

K02.1

ICD-10 Finland

Caries of dentine

1.3

6.8

814

7088

RJ410, ,

NOMESCO Finland

8.3

6.8

M54.5

ICD-10 Finland

Low back pain

1.4

6.8

518

4217

AA1DM

NOMESCO Finland

Very extensive MRI examination of brain with 3 Tesla magnet

4.1

6.8

K29

ICPC

Cardiovascular sympt/complt other

2.2

6.8

255

K59.1

ICD-10 Finland

Functional diarrhoea

1.9

6.8

470

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.4

6.8

371

2863

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

2.5

6.8

173

H10.9

ICD-10 Finland

Conjunctivitis, unspecified

1.8

6.8

105

611

129

Kela drug reimbursment

Idiopathic thrombocytopaenia or granulocytopenia

11.0

6.8

N06AX21

ATC

duloxetine; oral

1.6

6.8

178

1189

SCA02

NOMESCO Finland

Preventive oral health care

1.6

6.8

144

914

WX320

NOMESCO Finland

Spinalanesthesy

1.4

6.8

323

2435

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic

1.4

6.8

431

3412

N05BB01

ATC

hydroxyzine; systemic

1.9

6.8

493

J06BA01

ATC

immunoglobulins, normal human, for extravascular adm.; systemic

16.8

6.7

ZZH21

NOMESCO Finland

Graft of patients own bone, small pieces

2.8

6.7

121

WVA20

NOMESCO Finland

Medicine administration

2.5

6.7

174

JC2KB

NOMESCO Finland

Functional X-ray examination of swallowing

3.9

6.7

Z46.8

ICD-10 Finland

Fitting and adjustment of other specified devices

2.5

6.7

156

I77.6

ICD-10 Finland

Arteritis, unspecified

22.6

6.7

TJA33

NOMESCO Finland

Percutaneous introduction of peritoneal dialysis catheter

22.6

6.7

JJ1LE

NOMESCO Finland

Ultrasound elastography of liver

3.7

6.6

N89.0

ICD-10 Finland

Mild vaginal dysplasia

6.5

6.6

I20.90

ICD-10 Finland

Angina pectoris, unspecified

2.5

6.6

169

H26.4

ICD-10 Finland

After-cataract

1.7

6.6

128

793

Z01.2

ICD-10 Finland

Dental examination

1.3

6.6

649

5482

R05

ICPC

Cough

1.4

6.6

355

2730

C08CA13

ATC

lercanidipine; oral

1.5

6.6

185

1254

CA1CG

NOMESCO Finland

Eye and orbita extensive MRI examination with high intensity magnet

5.5

6.6

TPH07

NOMESCO Finland

Cathetrisation of artery

1.7

6.6

129

802

NE1BA

NOMESCO Finland

Pelvis extensive X-ray examination

3.2

6.6

A02BX02

ATC

sucralfate; oral

2.2

6.6

246

NG1DA

NOMESCO Finland

X-ray of knees

2.8

6.6

117

XF402

NOMESCO Finland

ECG with work load test

1.7

6.6

120

733

AN1

Coronary angiography

1.7

6.5

108

641

K90.9

ICD-10 Finland

Intestinal malabsorption, unspecified

10.1

6.5

WZA90

NOMESCO Finland

Other medical or dental certificate

1.4

6.5

313

2361

TDM10

NOMESCO Finland

Puncture of maxillary antrum

2.1

6.5

267

H03AA01

ATC

levothyroxine sodium; systemic

1.4

6.5

351

2702

I20.00

ICD-10 Finland

Unstable angina

2.6

6.5

135

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.4

6.5

379

2956

R58

ICD-10 Finland

Haemorrhage, not elsewhere classified

3.2

6.5

U02

ICPC

Urinary frequency/urgency

1.5

6.4

221

1564

0539X

ICD-9 Finland

Herpes zoster without mention of complication

70.2

6.4

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.6

6.4

153

1001

NA3EA

NOMESCO Finland

Lumbar spine X-ray examination with flexion

2.3

6.4

191

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.4

6.4

274

2025

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

1.8

6.4

518

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

1.7

6.3

110

662

PH1AE

NOMESCO Finland

Ultrasound examination of upper extremity veins

2.8

6.3

108

E27.3

ICD-10 Finland

Drug-induced adrenocortical insufficiency

8.2

6.3

K23.8*B37.8

ICD-10 Finland

Esophagitis caused by candidiasis

8.2

6.3

SFA10

NOMESCO Finland

One-surface restoration

1.3

6.3

758

6574

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

1.7

6.3

106

632

L14

ICPC

Leg/thigh symptom/complaint

1.7

6.3

117

717

J01DA06

ATC

[U] cefuroxime

1.5

6.3

188

1292

M05BX03

ATC

strontium ranelate; oral

6.0

6.3

J01XE01

ATC

nitrofurantoin; oral

2.8

6.3

114

N32.1

ICD-10 Finland

Vesicointestinal fistula

11.1

6.3

O99.7

ICD-10 Finland

Diseases of the skin and subcutaneous tissue complicating pregnancy, childbirth and the puerperium

11.1

6.3

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.4

6.3

255

1864

I25.2

ICD-10 Finland

Old myocardial infarction

2.1

6.3

264

J31.0

ICD-10 Finland

Chronic rhinitis

1.7

6.3

120

742

120

Kela drug reimbursment

Hypogammaglobulinaemia

18.1

6.3

O9989, M329,

ICD-10 Finland

+∞

6.3

N085M, ,

ICD-10 Finland

+∞

6.3

N085, M328,

ICD-10 Finland

+∞

6.3

M31.2

ICD-10 Finland

Lethal midline granuloma

+∞

6.3

M30.8

ICD-10 Finland

Other conditions related to polyarteritis nodosa

+∞

6.3

M30.0

ICD-10 Finland

Polyarteritis nodosa

+∞

6.3

J99.1*M35.0

ICD-10 Finland

Respiratory disorders in sicca syndrome [Sjögren]

+∞

6.3

M30.1

ICD-10 Finland

Polyarteritis with lung involvement [Churg-Strauss]

+∞

6.3

E32.9

ICD-10 Finland

Disease of thymus, unspecified

+∞

6.3

N085, M318,

ICD-10 Finland

+∞

6.3

S01

ICPC

Pain/tenderness of skin

2.0

6.2

340

I11.0

ICD-10 Finland

Hypertensive heart disease with (congestive) heart failure

2.6

6.2

132

7148X

ICD-9 Finland

Rheumatoid arthritis and other inflammatory polyarthropathies, Other specified inflammatory polyarthropathies

26.8

6.2

S22.0

ICD-10 Finland

Fracture of thoracic vertebra

2.7

6.2

115

LEB30

NOMESCO Finland

Destruction of lesion of vaginal mucosa

5.0

6.2

A08

ICPC

Swelling

1.9

6.2

434

I15.9

ICD-10 Finland

Secondary hypertension, unspecified

4.0

6.2

NDG30

NOMESCO Finland

Fusion of wrist, total

6.3

6.2

C07AA07

ATC

sotalol; systemic

2.4

6.2

169

J12.9

ICD-10 Finland

Viral pneumonia, unspecified

5.4

6.2

R20.2

ICD-10 Finland

Paraesthesia of skin

1.7

6.2

103

614

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

1.9

6.2

442

K22.4

ICD-10 Finland

Dyskinesia of oesophagus

5.8

6.1

N05BA01

ATC

diazepam; systemic, rectal

1.5

6.1

172

1167

A02BA03

ATC

famotidine; systemic

2.2

6.1

214

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

1.8

6.1

547

E000003, ,

ATC

2.0

6.1

308

R2110

NOMESCO Finland

Giving the first information

1.8

6.1

570

G62.8

ICD-10 Finland

Other specified polyneuropathies

4.1

6.1

NG4AA

NOMESCO Finland

Lower leg X-ray examination

2.2

6.1

221

DFF00

NOMESCO Finland

Pure tone audiometry

1.6

6.1

131

835

N11.9

ICD-10 Finland

Chronic tubulo-interstitial nephritis, unspecified

12.6

6.1

K75.4

ICD-10 Finland

Autoimmune hepatitis

12.6

6.1

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.5

6.1

165

1111

B01AB10

ATC

tinzaparin; parenteral

1.6

6.1

145

948

M54.0

ICD-10 Finland

Panniculitis affecting regions of neck and back

3.1

6.1

WX202

NOMESCO Finland

Supraclavicular plexus blockade

3.1

6.1

I80.8

ICD-10 Finland

Phlebitis and thrombophlebitis of other sites

3.1

6.1

S70

ICPC

Herpes zoster

2.4

6.0

177

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.7

6.0

102

610

N05CD07

ATC

temazepam; oral

1.6

6.0

138

893

C08DB01

ATC

diltiazem; oral

2.0

6.0

296

R03BB04

ATC

tiotropium bromide; inhalant

1.7

6.0

112

688

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

390

282

18.59

307.65

2.0

1.1

59.33

25.01

u/ml

2.10

107

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

193

52.90

307.65

1.5

1.1

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

515

363

21.51

307.65

2.1

1.1

39.47

7.61

u/ml

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

876

351

62.04

307.65

7.6

1.2

1.04

1.23

g/l

19.63

852

331

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

449

257

24.92

307.65

2.0

1.1

2.11

9.93

u/ml

—

(3037522) Nuclear Ab [Titer] in Serum

836

1828

9.50

307.65

2.8

1.3

1022.06

373.11

titre

21.52

524

366

(3015171) Extractable nuclear Ab [Units/volume] in Serum

466

490

13.57

307.65

2.0

1.2

3.05

0.93

u/ml

1.17

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

272

156

21.26

307.65

1.8

1.1

15.48

2.20

u/ml

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

511

332

23.29

307.65

2.1

1.1

18.48

2.10

u/ml

3.57

171

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

877

333

65.66

307.65

7.6

1.2

0.18

0.25

g/l

26.56

846

315

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

506

334

22.80

307.65

2.1

1.2

13.45

2.95

u/ml

5.05

201

(3023420) DNA double strand Ab [Units/volume] in Serum

891

497

45.30

307.65

9.0

1.3

25.14

4.63

iu/ml

10.96

493

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

214

101

24.71

292.49

1.8

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

203

27.96

291.82

1.8

1.1

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

266

202

15.92

289.22

1.7

1.2

5.75

4.47

u/ml

0.39

170

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

203

26.38

285.47

1.8

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

198

27.16

281.84

1.8

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

199

26.68

281.30

1.8

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

199

26.68

281.30

1.8

1.1

—

(3018333) Ribosomal P Ab [Presence] in Serum

195

28.03

281.00

1.8

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

196

27.51

280.41

1.8

1.1

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

252

210

14.33

258.74

1.7

1.2

9.42

2.92

u/ml

2.35

154

(3005719) IgG [Mass/volume] in Serum or Plasma

476

963

6.89

240.19

4.4

2.7

11.19

10.57

g/l

1.71

460

887

(4268621) Lupus anticoagulant assay

204

143

16.45

230.51

3.0

2.2

—

(42870588) Differential panel, method unspecified - Blood

992

4269

5.24

198.41

15.9

5.8

—

(3004616) Nuclear Ab [Presence] in Serum

180

138

14.76

192.78

2.0

1.2

—

(3019069) Monocytes/Leukocytes in Blood

1171

6074

5.94

176.46

18.5

6.0

9.27

8.61

9.90

1137

5693

(3001604) Monocytes [#/volume] in Blood

1226

6613

6.70

175.85

18.2

5.9

0.56

e9/l

0.04

1160

5702

(3006315) Basophils [#/volume] in Blood

1227

6628

6.71

175.54

18.3

5.9

0.04

e9/l

5.95

1160

5708

(3006504) Eosinophils/Leukocytes in Blood

1166

6057

5.83

174.50

18.4

5.9

2.47

2.79

5.23

1132

5673

(3022096) Basophils/Leukocytes in Blood

1165

6051

5.82

174.28

18.6

6.0

0.68

0.70

0.39

1135

5651

(3018010) Neutrophils/Leukocytes in Blood

1173

6129

5.90

174.08

17.8

5.8

58.72

56.74

6.62

1143

5857

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

145

17.04

169.79

1.8

1.1

59.93

—

u/ml

—

(3013115) Eosinophils [#/volume] in Blood

1235

6854

6.59

166.68

18.7

6.1

0.15

0.18

e9/l

16.60

1174

5998

(3002030) Lymphocytes/Leukocytes in Blood

1172

6236

5.70

166.61

18.3

5.9

26.63

28.58

8.09

1146

5921

(3019198) Lymphocytes [#/volume] in Blood

1225

6778

6.36

165.19

18.4

5.9

1.65

1.92

e9/l

13.18

1174

5996

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

244

380

7.53

154.42

1.4

1.1

—

(3028026) IgM [Mass/volume] in Serum or Plasma

345

765

5.61

152.54

2.1

1.8

1.29

1.37

g/l

0.36

321

707

(3013650) Neutrophils [#/volume] in Blood by Automated count

1257

7468

6.33

145.18

21.1

9.3

3.79

3.97

e9/l

2.45

1193

6517

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

426

1299

4.24

124.85

3.9

4.5

242.39

246.45

u/l

0.21

415

1242

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

235

476

5.70

113.09

2.4

1.8

1.50

1.52

g/l

0.11

211

413

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

774

3761

3.28

107.31

3.4

2.1

191.58

190.17

u/l

0.01

751

3567

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

16.40

105.92

1.5

1.1

39.04

9.50

u/ml

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

206

403

5.80

102.57

1.6

1.5

0.10

0.06

iu/ml

0.22

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

14.77

102.24

1.3

1.1

—

(3020630) Protein [Mass/volume] in Serum or Plasma

326

952

4.13

99.40

2.1

3.1

66.04

66.94

g/l

1.15

307

881

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

13.09

99.25

1.4

1.1

1.12

1.05

ratio

1.74

(3004588) Protein electrophoresis panel - Serum or Plasma

288

770

4.42

98.82

1.9

2.7

—

(3021601) Nitrite [Presence] in Urine by Test strip

1107

6858

3.64

98.32

8.0

3.8

0.00

estimate

0.50

256

1401

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1037

6192

3.40

97.51

3.9

2.5

81.51

77.68

nmol/l

4.61

998

5643

(3035350) Ketones [Presence] in Urine by Test strip

1111

6939

3.62

96.46

8.0

3.8

20.10

3.41

estimate

0.98

263

1440

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

1050

6342

3.41

96.28

11.5

6.8

1.22

mmol/l

0.65

953

5507

(3004789) Transferrin [Mass/volume] in Serum or Plasma

489

1913

3.35

95.49

3.7

2.4

2.20

2.37

g/l

8.93

469

1774

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

463

1752

3.42

95.44

3.7

2.4

21.78

22.43

0.49

443

1638

(3015736) pH of Urine

961

5535

3.21

95.17

6.3

3.4

6.32

6.24

1.39

502

3138

(3009261) Glucose [Presence] in Urine by Test strip

1113

6994

3.59

94.89

8.1

3.8

0.02

0.24

estimate

0.49

253

1359

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

147

221

7.29

94.83

6.0

5.6

259.25

284.04

iu/ml

0.06

(3000850) Epithelial cells [#/volume] in Urine

604

2719

3.10

92.28

5.5

2.5

4.60

7.51

e6/l

6.42

571

2470

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

128

176

7.88

89.28

2.7

3.3

100.00

547.64

u/ml

—

(3022948) Iron [Moles/volume] in Serum or Plasma

504

2080

3.19

89.03

3.8

2.4

11.69

13.22

umol/l

5.78

485

1936

(3002179) Metamyelocytes/Leukocytes in Blood

340

1099

3.74

88.85

7.2

3.9

0.46

0.79

2.87

151

303

(3027945) Reticulocytes/Erythrocytes in Blood

375

1302

3.54

87.78

3.9

2.7

1.81

1.83

0.15

349

1165

(3024561) Albumin [Mass/volume] in Serum or Plasma

953

5619

3.05

87.45

8.0

4.7

34.80

36.19

g/l

11.87

909

5291

(3017732) Neutrophils [#/volume] in Blood

435

1663

3.31

87.16

3.6

3.1

3.83

4.98

e9/l

2.13

371

1468

(3018095) Leukocytes [#/volume] in Urine

843

4669

2.94

86.55

9.5

3.7

74.11

100.17

e6/l

0.62

659

3172

(3002582) Erythrocytes [#/volume] in Urine

754

3958

2.90

85.25

7.3

3.1

92.85

76.47

e6/l

0.09

640

2981

(3023520) Reticulocytes [#/volume] in Blood

310

966

3.81

85.24

3.3

2.7

69.67

72.08

e9/l

0.47

210

714

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

951

5669

2.99

84.21

9.6

6.1

1.22

mmol/l

0.54

913

5235

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

14.47

84.04

1.2

1.0

—

(3017181) Myelocytes/Leukocytes in Blood

340

1153

3.55

82.05

8.0

4.0

0.66

1.12

3.57

145

323

(3023368) Bacteria identified in Blood by Culture

632

3130

2.81

78.11

6.4

4.1

—

(3045424) Erythrocytes [Presence] in Urine

226

603

4.26

76.75

3.3

2.0

0.00

0.02

estimate

0.68

195

(3011412) CD3 cells [#/volume] in Blood

10.23

76.69

2.6

2.5

882.77

1223.82

e6/l

1.85

(3033099) Centromere Ab [Titer] in Serum

26.16

76.11

1.3

1.2

—

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

1302

9596

4.68

75.77

15.0

4.0

15.65

11.74

mm/h

18.67

1273

8999

(3030467) Casts [#/volume] in Urine by Automated count

664

3413

2.75

75.76

7.2

2.9

0.26

0.42

e6/l

1.62

550

2461

(40768446) Kidney Pathology biopsy report

19.80

75.71

1.3

1.6

—

(3020779) Urea [Moles/volume] in Serum or Plasma

296

965

3.60

75.41

10.7

6.9

9.75

8.94

mmol/l

1.16

289

929

(3021440) Promyelocytes/Leukocytes in Blood

320

1097

3.46

75.40

8.2

4.0

0.01

0.15

6.00

125

265

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

186

440

4.71

73.62

1.7

2.4

3.09

2.88

g/l

1.71

175

404

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

662

3435

2.71

73.60

3.9

2.9

1322.77

1000.64

ng/l

1.34

587

2886

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

141

262

5.86

73.53

1.4

1.5

—

(3025159) Blasts/Leukocytes in Blood

319

1108

3.41

73.46

8.5

4.3

0.35

0.14

0.30

122

243

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

191

466

4.57

72.71

1.7

2.3

3.50

3.74

g/l

1.24

180

431

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

191

467

4.56

72.50

1.7

2.3

7.21

7.41

g/l

0.81

180

431

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

191

467

4.56

72.50

1.7

2.3

4.12

4.30

g/l

1.93

180

430

(3007164) IgA [Mass/volume] in Serum or Plasma

579

2838

2.74

71.68

1.9

1.5

2.38

2.30

g/l

0.55

404

1748

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

175

407

4.76

70.64

1.8

2.5

0.32

1.23

g/l

2.69

159

350

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

173

399

4.79

70.55

1.8

2.3

11.54

10.28

g/l

2.39

160

361

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

160

348

5.05

69.96

1.8

2.2

0.00

0.02

g/l

0.51

148

311

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

1302

9792

4.40

68.97

18.4

7.7

74.17

77.60

u/l

2.11

1282

9290

(40768443) Skin Pathology biopsy report

209

576

4.07

67.57

1.3

1.2

—

(3034426) Prothrombin time (PT)

15.34

66.78

1.4

1.3

29.98

28.00

0.69

(3018418) pH of Serum or Plasma

696

3832

2.58

66.78

6.7

3.8

7.40

0.62

548

2695

(3003458) Phosphate [Moles/volume] in Serum or Plasma

386

1600

2.93

64.86

9.7

5.3

1.08

1.04

mmol/l

1.65

364

1480

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

146

313

5.08

64.81

1.8

2.2

0.00

g/l

-0.00

139

296

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

112

188

6.37

64.66

1.4

1.1

673.33

106.67

titre

—

(3045414) Leukocytes [Presence] in Urine

321

1210

3.13

63.78

3.1

2.1

0.00

0.02

estimate

0.78

245

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

10.93

63.39

2.0

1.2

5.72

6.23

u/l

0.22

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

151

342

4.81

62.76

1.8

2.2

0.00

g/l

-0.00

139

296

(3026782) Osmolality of Urine

487

2327

2.65

61.72

6.2

2.7

498.08

510.40

mosm/kgh2o

0.70

450

2039

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

616

3368

2.45

57.82

3.2

2.2

2.88

2.78

mg/l

0.41

560

2916

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

10.26

56.34

2.6

407.58

584.17

e6/l

0.61

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

9.82

55.43

2.7

2.5

120.90

228.89

e6/l

3.40

(3014051) Protein [Presence] in Urine by Test strip

664

3807

2.38

55.37

5.6

2.9

0.17

0.00

0.47

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

9.95

55.13

2.3

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

493

2482

2.50

54.89

1.4

1.3

14.93

12.16

u/ml

0.34

208

972

(3011397) Hemoglobin [Presence] in Urine by Test strip

579

3146

2.40

54.33

7.0

3.7

0.00

0.16

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

103

191

5.73

53.57

1.6

1.5

0.50

0.74

g/l

1.65

160

(40760892) CBC W Ordered Manual Differential panel - Blood

563

3044

2.39

53.18

11.0

4.5

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

347

1495

2.74

53.02

1.7

1.5

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

512

2668

2.43

52.41

1.4

1.3

40.74

31.13

iu/ml

0.82

177

809

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

181

539

3.70

51.88

1.7

2.1

40.07

40.04

u/l

0.01

165

488

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

430

2094

2.50

50.82

5.7

2.7

0.96

1.16

e6/l

0.53

280

1052

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

143

367

4.22

50.47

2.3

2.0

159.31

252.05

ug/l

1.05

135

344

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

111

233

5.08

50.28

1.3

1.4

—

(3021589) Normoblasts [#/volume] in Blood

873

5786

2.29

49.81

23.0

10.5

0.00

e9/l

0.32

780

4743

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

265

1022

2.95

49.61

5.8

3.5

91.71

80.24

ng/l

1.39

243

894

(3034860) Kappa light chains.free [Mass/volume] in Serum

140

363

4.16

48.71

1.9

4.2

48.31

63.49

mg/l

0.43

117

317

(3036481) Cortisol [Moles/volume] in Serum or Plasma

311

1318

2.73

48.68

2.1

349.06

383.00

nmol/l

2.27

286

1226

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

140

364

4.15

48.52

1.9

4.2

39.25

54.22

mg/l

0.71

117

319

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

966

6735

2.32

47.98

7.6

6.3

10.12

10.76

umol/l

0.99

929

6409

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

403

1960

2.47

47.29

2.6

1.8

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

100

207

5.12

45.99

1.3

1.5

159.55

147.30

au/ml

0.43

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

12.52

45.46

1.3

1.1

—

(3034770) Mitochondria Ab [Titer] in Serum

134

354

4.07

45.39

1.4

1.2

1395.00

1048.18

titre

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

7.74

45.22

1.5

1.1

403.75

99.09

titre

2.00

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

105

232

4.80

44.71

1.3

336.64

264.52

u/ml

0.71

136

(3007566) Smooth muscle Ab [Titer] in Serum

132

349

4.06

44.65

1.3

1.2

223.64

97.65

titre

0.55

(3042936) Bacteria identified in Isolate by Culture

364

1740

2.46

43.95

2.6

2.0

—

(37208534) Antinuclear antibody arbitrary concentration in serum

11.58

43.27

1.8

1.0

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

126

331

4.08

42.97

1.7

2.2

12.26

11.75

mg/l

0.29

117

311

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

123

323

4.07

41.95

1.8

4.0

3.02

3.58

ratio

0.13

188

(3032080) INR in Blood by Coagulation assay

808

5428

2.11

41.42

22.4

12.4

1.29

1.19

inr

5.13

707

4493

(3018677) aPTT in Platelet poor plasma by Coagulation assay

366

1805

2.38

40.87

3.0

2.0

30.32

29.13

2.27

358

1753

(3021879) Hepatitis B virus core Ab [Presence] in Serum

243

988

2.76

40.69

1.4

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

378

1906

2.33

40.00

6.3

2.8

2.42

3.48

e6/l

1.58

228

863

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

128

358

3.83

39.94

4.5

3.8

1.69

1.44

mg/l

2.30

121

324

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

7.98

39.30

2.2

2.9

41.50

42.47

0.09

(3021447) Carbon dioxide [Partial pressure] in Venous blood

269

1173

2.59

39.07

4.9

3.3

5.80

5.79

kpa

0.08

258

1140

(3020876) Protein [Mass/time] in 24 hour Urine

129

5.82

38.73

2.5

2.6

1.15

1.22

g/24h

0.09

(3029937) Albumin [Presence] in Urine by Test strip

613

3797

2.07

38.16

8.3

3.9

0.00

0.01

estimate

1.74

246

1340

(3037756) Immunofixation for Serum or Plasma

102

250

4.31

38.09

1.2

1.7

—

(3031040) Bacteria [#/volume] in Urine by Automated count

1104

8498

2.28

38.08

7.4

4.6

1347.18

2215.50

e6/l

0.31

110

(3012095) Magnesium [Moles/volume] in Serum or Plasma

393

2053

2.26

37.98

4.0

3.4

0.82

mmol/l

0.09

375

1947

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

12.17

37.76

1.2

1.0

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

12.17

37.76

1.2

1.0

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

12.17

37.76

1.2

1.0

—

(3013637) Mi-2 Ab [Presence] in Serum

12.17

37.76

1.2

1.0

—

(3012544) pH of Venous blood

265

1173

2.54

37.17

5.0

3.4

7.37

7.38

1.24

159

662

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

120

340

3.76

36.71

2.7

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

409

2202

2.20

36.49

1.7

—

(3002032) Base excess in Venous blood by calculation

257

1138

2.53

35.93

5.0

3.3

1.55

1.85

mmol/l

0.59

222

988

(3000494) Fungus identified in Specimen by Culture

326

1609

2.33

35.81

1.7

1.4

—

(3037121) Protein [Mass/volume] in Urine

134

416

3.45

35.71

5.2

3.2

347.75

323.88

mg/l

0.11

164

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

302

1451

2.37

35.24

2.3

1.7

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

229

970

2.62

35.05

4.5

2.4

0.19

0.54

e6/l

2.36

222

921

(3009508) Creatinine [Moles/volume] in Urine

655

4279

1.97

33.98

6.8

3.3

6.83

7.23

mmol/l

1.56

592

3664

(3000475) Leukocytes [#/volume] in Synovial fluid

108

300

3.81

33.96

1.9

1.6

15869.11

12203.27

e6/l

0.20

221

(40758558) Short blood count panel - Blood

624

4034

1.96

33.14

12.0

5.9

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

133

433

3.28

32.80

2.1

2.0

1.32

1.61

ug/l

0.14

126

382

(3026493) Urate [Moles/volume] in Serum or Plasma

514

3124

2.00

32.49

3.9

2.6

333.78

322.29

umol/l

1.53

468

2770

(3001122) Ferritin [Mass/volume] in Serum or Plasma

902

6628

1.96

32.45

4.6

3.1

159.07

94.85

ug/l

8.94

863

6231

(4062490) Immunoglobulin typing, IgG

114

5.64

32.43

1.5

1.4

—

(3026008) Bacteria identified in Urine by Culture

638

4183

1.94

32.26

4.0

3.1

—

(3010375) cycloSPORINE [Mass/volume] in Blood

9.97

32.19

33.4

35.3

98.00

117.47

ug/l

0.84

(3020682) Albumin/Creatinine [Ratio] in Urine

622

4048

1.94

32.11

8.1

4.0

18.24

7.76

mg/mmol

3.00

437

2457

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

7.93

32.01

1.3

1.4

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

7.93

32.01

1.3

1.4

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

113

5.59

31.66

1.5

1.3

0.52

0.35

g/l

1.14

(3028192) IgG subclass 2 [Mass/volume] in Serum

113

5.59

31.66

1.5

1.3

2.74

2.81

g/l

0.10

(3027135) IgG subclass 1 [Mass/volume] in Serum

113

5.59

31.66

1.5

1.3

7.32

6.59

g/l

0.58

(21494814) CD8 cells/Lymphocytes in Specimen

10.53

31.65

2.3

2.1

32.77

31.56

0.15

(3012516) Albumin [Mass/volume] in Urine

611

3972

1.93

31.48

6.9

3.4

99.77

39.30

mg/l

4.32

425

2459

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

206

873

2.59

31.32

2.1

1.7

—

(3035715) Granulocytes [#/volume] in Blood

221

4.13

30.94

5.2

3.4

3.64

4.17

e9/l

1.64

221

(3007853) Bacteria identified in Skin by Aerobe culture

294

1472

2.25

30.76

2.2

1.6

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

107

316

3.58

30.72

1.6

1.4

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

497

3051

1.96

30.03

2.5

1.7

1.46

1.07

mg/l

2.34

410

2336

(46235355) HIV 1 and 2 tests - Meaningful Use set

433

2548

2.00

29.47

1.9

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

107

325

3.48

29.42

1.6

1.5

—

(3019225) pH of Specimen

249

1183

2.34

29.39

7.1

3.9

7.37

7.35

1.16

211

852

(3008757) Leukocyte morphology finding [Identifier] in Blood

107

5.51

29.16

3.5

3.6

—

(3035933) Granulocytes/Leukocytes in Blood

283

3.64

29.08

5.0

3.2

59.80

58.72

0.33

283

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

180

740

2.64

29.02

5.8

3.6

5.10

5.16

kpa

0.50

175

719

(3048929) Epstein Barr virus Ab [Presence] in Serum

127

433

3.12

28.95

1.3

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

277

1390

2.23

28.65

2.4

1.8

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

116

379

3.24

28.38

4.3

2.5

194.73

182.59

0.68

109

363

(3033658) Prothrombin time (PT) actual/Normal

506

3178

1.91

28.18

5.9

3.8

91.61

93.65

0.99

493

3107

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

101

304

3.50

28.15

4.3

3.2

0.33

0.38

iu/ml

0.83

168

(3022313) Gas panel - Capillary blood

141

519

2.90

28.07

6.0

3.7

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

202

893

2.47

27.94

2.7

2.5

31.53

22.43

au/ml

0.43

(3009343) pH of Capillary blood

175

724

2.61

27.81

5.6

3.6

7.42

0.30

149

622

(3015377) Calcium [Moles/volume] in Serum or Plasma

671

4641

1.83

27.31

4.1

3.5

2.33

2.36

mmol/l

5.68

620

4239

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

189

819

2.50

27.26

1.4

1.3

60.27

42.26

au/ml

0.54

(3019309) Folate [Moles/volume] in Red Blood Cells

351

1979

2.02

26.56

1.9

1.7

1125.32

1191.55

nmol/l

0.74

287

1519

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

186

812

2.48

26.37

4.3

2.9

208.85

176.46

ng/l

0.39

174

739

(3000093) Morphology [Interpretation] in Blood Narrative

103

5.30

26.11

1.2

1.1

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

115

393

3.09

26.07

2.6

1.8

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

522

3379

1.85

26.00

1.5

1.3

1.29

1.62

u/ml

0.27

126

937

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

772

5630

1.80

25.84

2.4

2.1

101.21

97.45

pmol/l

1.42

436

2910

(3021960) Folate [Moles/volume] in Serum or Plasma

547

3606

1.83

25.59

2.0

1.7

19.08

21.09

nmol/l

2.88

480

3060

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

106

5.15

25.29

1.4

1.2

—

titre

—

(3036489) Thrombin time

130

487

2.83

25.00

3.7

2.1

21.56

20.69

0.67

117

432

(3000991) Gas panel - Venous blood

209

985

2.31

24.90

9.0

8.1

—

(3041096) Erythrocytes [Presence] in Urine by Automated

566

3796

1.81

24.84

6.9

3.2

0.00

0.31

estimate

0.76

221

1137

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

221

3.72

24.55

1.5

1.3

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

111

389

3.01

24.07

1.4

1.3

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

723

5250

1.76

23.85

7.7

3.7

0.00

0.15

estimate

1.00

221

1156

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

119

439

2.86

23.53

2.7

1.9

—

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

5.31

23.25

1.7

1.5

—

(3024354) Oxygen [Partial pressure] in Venous blood

204

982

2.25

23.03

4.1

2.9

4.60

4.51

kpa

0.28

193

954

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

100

5.04

22.85

1.1

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

151

639

2.52

22.77

5.5

3.5

1.54

1.87

mmol/l

0.37

119

480

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

338

3.07

22.46

1.6

1.5

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

211

3.64

22.36

1.5

1.6

—

(40768797) Stomach Pathology biopsy report

321

1850

1.95

22.36

1.3

1.2

—

(36660697) Celiac disease serology panel - Serum

226

1147

2.15

22.33

1.3

1.2

—

(3048689) Calprotectin [Mass/mass] in Stool

322

1864

1.94

22.11

2.8

2.4

114.47

115.96

ug/g

0.03

269

1482

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

625

4427

1.73

21.93

4.2

3.1

33.54

30.50

u/l

0.85

595

4203

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

647

4632

1.72

21.80

4.6

3.5

158.33

40.39

ng/l

0.55

476

3023

(3035947) Staphylolysin Ab [Units/volume] in Serum

7.83

21.73

1.1

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

142

4.21

21.66

1.1

1.2

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

101

4.88

21.61

1.1

294.00

232.59

mg/l

0.93

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

335

3.03

21.57

1.5

1.3

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

932

7396

1.74

21.29

6.2

4.7

6.27

6.59

mmol/l

5.54

898

6970

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

231

1208

2.09

21.04

2.6

2.2

0.19

0.22

g/l

4.18

216

1136

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

133

4.26

20.88

1.5

1.6

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

147

4.07

20.69

1.4

1.5

—

(4195642) Thrombophilia screening test

193

3.65

20.69

1.4

1.2

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

243

3.34

20.58

1.4

1.3

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

296

3.10

20.47

1.5

1.3

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

106

4.65

20.41

1.3

1.2

55.60

35.68

mg/l

1.18

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

375

2341

1.81

20.08

5.4

3.6

462.67

332.09

ng/l

0.32

300

1663

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

149

666

2.38

19.89

2.0

1.7

—

(3028433) Virus identified in Specimen by Culture

7.84

19.59

1.4

1.3

—

(3019174) dRVVT (LA screen)

19.70

19.54

1.4

1.1

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

573

4060

1.68

19.41

3.0

2.5

58.07

60.59

u/l

0.51

537

3752

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

8.01

19.19

1.4

9.00

8.70

ug/l

0.09

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

105

406

2.71

18.96

1.3

—

(3044009) aPTT.lupus sensitive (LA screen)

19.01

18.67

1.6

1.2

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

5.32

18.49

1.1

—

(44806071) Cardiolipin IgM antibody measurement

15.29

18.47

1.1

—

(3044640) Blood type and Crossmatch panel - Blood

586

4216

1.66

18.47

2.9

2.3

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

7.93

18.32

2.2

2.5

0.62

mmol/l

0.01

(3052851) Hemolysis interference index of Serum or Plasma

322

2.88

18.21

3.8

3.1

2.26

2.07

index

0.05

160

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

285

2.99

18.03

1.2

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

467

3185

1.69

17.96

2.8

2.3

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

119

4.14

17.65

1.6

1.7

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

204

3.29

16.97

1.5

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

204

3.29

16.97

1.5

1.3

—

(3044941) Cell count panel - Synovial fluid

222

3.17

16.65

1.7

1.5

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

367

2.64

16.14

1.2

1.1

6.18

3.74

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

185

3.34

16.12

1.4

1.5

—

(3006571) Granulocytes/Leukocytes in Synovial fluid

132

3.81

16.10

1.8

1.7

55.11

59.69

0.33

(3023199) Leukocytes [#/volume] in Pleural fluid

103

4.17

15.68

1.5

1.3

4112.03

2025.75

e6/l

0.87

(4027681) Cerebrospinal fluid IgG ratio and IgG index

4.55

15.46

1.3

1.2

0.54

ratio

0.00

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

198

3.17

15.09

1.3

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

11.44

14.79

1.3

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

247

1478

1.81

14.75

2.8

6.78

6.84

umol/l

0.02

218

1280

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

212

3.06

14.68

1.3

1.1

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

405

2.47

14.52

1.4

1.3

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

5.47

14.51

1.1

1.2

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

241

2.91

14.47

1.7

1.6

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

4.85

14.05

1.7

1.6

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

4.85

14.05

1.7

1.6

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

4.85

14.05

1.7

1.6

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

4.85

14.05

1.7

1.6

—

(3012441) Differential panel - Pleural fluid

4.15

13.78

1.4

1.5

—

(3005322) IgE [Units/volume] in Serum or Plasma

179

987

1.93

13.77

1.2

1.3

125.70

187.96

u/ml

0.84

162

911

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

157

3.33

13.76

1.4

1.1

80.38

97.06

3.14

146

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

1354

12532

2.32

13.60

37.6

14.2

19.29

21.76

mg/l

2.85

1257

10232

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

382

2631

1.61

13.45

3.1

2.7

2.46

2.45

mmol/l

0.57

349

2379

(40768806) Pleura Pathology biopsy report

4.06

13.40

1.4

1.7

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

130

3.54

13.39

1.1

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

203

2.99

13.25

1.3

1.1

111.61

118.05

0.62

187

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

117

3.67

13.19

1.2

1.1

—

(3044290) Cell count panel - Cerebral spinal fluid

277

2.68

13.16

1.3

1.5

—

(3039744) RNA polymerase III Ab [Units/volume] in Serum

28.64

12.97

1.1

1.2

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

411

2.35

12.71

1.4

341.46

296.91

ug/g

1.25

241

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

164

906

1.91

12.52

2.6

2.3

6.76

6.44

ug/l

0.10

142

806

(3010144) Erythrocytes [#/volume] in Synovial fluid

112

3.64

12.48

1.6

1.3

203118.00

167324.78

e6/l

0.06

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

132

3.41

12.38

1.0

1.3

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

3.96

12.31

1.4

54465.58

126172.57

e6/l

0.34

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

9.74

12.24

1.2

1.1

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

318

2.50

12.20

1.6

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

259

2.66

12.14

1.4

1.3

—

(3044927) Protein electrophoresis panel - Urine

110

3.62

12.05

1.2

—

(44790047) Parainfluenza type 1 nucleic acid detection

176

3.03

12.03

1.7

1.3

—

(44806118) Parainfluenza type 4 nucleic acid detection

176

3.03

12.03

1.7

1.3

—

(44790049) Parainfluenza type 3 nucleic acid detection

176

3.03

12.03

1.7

1.3

—

(44790048) Parainfluenza type 2 nucleic acid detection

176

3.03

12.03

1.7

1.3

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

4.97

11.70

1.3

2.1

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

4.64

11.67

1.4

1.3

583.33

1009.09

titre

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

144

3.19

11.45

2.1

2.6

21.70

35.61

iu/ml

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

4.37

11.25

1.4

1.2

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

106

525

2.10

10.99

3.5

3.1

24.86

25.44

mmol/l

0.97

101

506

(3000060) B lymphocytes [#/volume] in Blood

8.33

10.82

1.7

2.1

0.14

0.17

e9/l

—

(3016018) Differential panel - Cerebral spinal fluid

139

3.16

10.77

1.3

1.6

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

169

990

1.80

10.68

5.4

3.6

1.23

mmol/l

0.75

160

837

(3047007) Chlamydophila sp Ab [Presence] in Serum

217

2.69

10.67

1.3

1.2

—

(3045788) Cell count panel - Pleural fluid

3.69

10.55

1.4

1.3

—

(3019150) Specific gravity of Urine by Refractometry

416

3058

1.51

10.55

7.4

4.0

1.02

1.52

kg/l

0.50

343

2022

(4035726) Immunohistochemistry procedure

186

1126

1.75

10.51

1.5

1.4

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

219

2.67

10.49

1.2

1.3

—

(40768441) Liver Pathology biopsy report

3.65

10.39

1.2

1.4

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

192

2.77

10.33

1.1

—

(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay

9.64

10.26

1.1

1.0

84.70

106.24

1.51

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

4.06

10.25

1.1

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

182

2.81

10.20

1.1

1.2

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

5.32

10.12

1.1

1.5

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

121

3.20

9.78

1.3

1.8

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

740

6134

1.42

9.77

3.5

2.7

—

estimate

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

3.72

9.73

1.2

1.1

—

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

4.48

9.56

2.8

1.8

62.74

69.61

ug/l

0.13

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

3.91

9.43

1.1

1.2

—

(3021901) Oxygen saturation in Capillary blood

221

2.55

9.28

2.8

89.47

90.28

0.29

215

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

203

1310

1.64

8.99

7.3

8.1

4.90

5.08

kpa

1.76

194

1268

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

256

2.40

8.93

1.1

18.83

23.31

au/ml

0.27

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

156

2.81

8.86

1.5

1.4

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

4.52

8.85

1.0

1.1

518.14

43.58

ng/l

—

(3019977) pH of Arterial blood

202

1309

1.63

8.80

7.4

8.1

7.43

7.42

2.42

106

737

(3027801) Oxygen [Partial pressure] in Arterial blood

202

1310

1.63

8.77

7.3

8.1

11.68

12.64

kpa

2.09

194

1270

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

114

629

1.88

8.72

1.8

1.5

—

(3017704) Immunofixation for Urine

3.90

8.71

1.0

1.7

—

(3042733) HLA Ab [Presence] in Serum

7.69

8.65

5.9

3.0

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

3.42

8.65

1.1

1.01

1.10

u/l

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

4.42

8.63

1.5

1.8

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

120

3.05

8.62

2.6

3.5

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

11.65

8.57

1.8

1.4

—

(3016502) Oxygen saturation in Arterial blood

181

1148

1.66

8.57

7.2

8.6

94.87

95.85

0.76

176

1117

(40768804) Tissue Pathology biopsy report

657

5420

1.39

8.47

2.4

2.1

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

166

2.70

8.44

1.7

1.4

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

3.92

8.43

1.8

1.4

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

3.92

8.43

1.8

1.4

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

4.33

8.41

1.5

1.8

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

4.33

8.41

1.5

1.8

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

3.42

8.37

1.4

1.1

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

167

2.69

8.34

1.7

1.4

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

4.25

8.21

1.0

1.1

251.47

181.24

iu/ml

0.29

(21494434) Karyotype in Bone marrow

108

3.10

8.16

1.1

1.2

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

4.78

8.12

1.1

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

300

2.22

8.10

1.4

1.5

1239.00

419.86

e6/l

0.38

234

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

164

2.67

8.08

1.7

1.4

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

3.38

7.95

1.1

1.4

22.12

24.04

umol/l

0.12

(3045142) Bone marrow Pathology biopsy report

137

2.82

7.94

1.1

1.3

—

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

160

1003

1.67

7.92

3.9

2.5

60.81

68.91

ml/min/173m2

1.73

422

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

297

2.21

7.88

1.3

1.5

17.06

31.90

e6/l

0.31

218

(3042631) Mycobacterium sp identified in Specimen

149

2.73

7.87

2.8

2.6

—

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

1293

12107

1.66

7.84

29.6

13.7

82.39

82.99

ml/min/173m2

0.41

1238

11193

(3010838) Calcium [Moles/time] in 24 hour Urine

259

2.29

7.82

1.8

2.1

4.26

4.88

mmol/24h

0.75

228

(21494890) Protein electrophoresis panel - 24 hour Urine

111

3.02

7.80

1.4

2.4

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

190

1249

1.60

7.78

2.9

2.3

38.62

41.59

u/l

0.26

162

1032

(3003396) Base excess in Arterial blood by calculation

196

1300

1.59

7.73

7.3

8.1

0.54

0.98

mmol/l

0.60

165

1079

(3037692) Legionella sp identified in Specimen by Organism specific culture

5.95

7.69

1.5

1.3

—

(1761868) Lipid panel - Serum or Plasma

411

5178

0.71

7.63

2.9

3.0

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

119

2.90

7.51

1.6

1.5

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

119

2.90

7.51

1.6

1.5

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

119

2.90

7.51

1.6

1.5

—

(3023419) Bacteria identified in Sputum by Culture

154

2.64

7.41

2.6

2.9

—

(3022621) pH of Urine by Test strip

165

1069

1.61

7.16

3.4

2.5

6.14

6.09

0.24

697

(3022145) Colonoscopy Study observation

218

1506

1.53

7.16

1.4

1.3

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

350

2.02

6.79

1.3

1.1

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

4.29

6.76

1.7

1.2

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

6.46

6.64

1.1

1.2

1.85

56.89

ug/l

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

6.46

6.64

1.1

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

6.46

6.64

1.1

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

157

2.53

6.63

1.7

1.5

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

157

2.53

6.63

1.7

1.5

—

(42529527) Centromere protein A Ab [Units/volume] in Serum by Line blot

8.73

6.55

1.0

1.1

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

158

2.51

6.55

1.7

1.4

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

3.95

6.45

1.9

1.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

3.95

6.45

1.9

1.4

—

(3003329) Lymphocytes/Leukocytes in Synovial fluid

2.95

6.44

2.0

1.6

26.01

35.52

0.71

(3003327) Ova and parasites identified in Stool by Light microscopy

496

1.82

6.35

2.2

1.7

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

5.54

6.30

1.1

1.2

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

9.30

6.29

1.8

1.7

—

(42528596) U1 small nuclear ribonucleoprotein A Ab [Presence] in Serum by Line blot

+∞

6.25

1.3

0.0

—

(42528597) U1 small nuclear ribonucleoprotein C Ab [Presence] in Serum by Line blot

+∞

6.25

1.3

0.0

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

368

1.95

6.25

1.3

1.2

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

215

1526

1.48

6.17

4.9

4.8

34.37

32.57

1.56

162

1033

(3028679) Herpes simplex virus Ab [Presence] in Serum

3.19

6.03

1.1

1.2

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

6.05

6.00

1.1

1.0

—

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

148

975

1.58

6.00

1.7

1.5

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

203

2.26

5.99

1.0

1.1

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

5.05

5.88

1.1

—

(3013247) Albumin in CSF/Albumin in Serum or Plasma

6.41

5.86

1.1

1.0

8.50

5.96

mg/g

0.58

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

144

952

1.57

5.75

2.8

3.6

4.23

4.51

pmol/l

3.03

129

844

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

1142

10582

1.38

5.71

5.4

4.8

14.82

14.66

pmol/l

1.38

1073

9830

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

145

2.45

5.65

3.0

2.2

40.25

24.94

mg/l

0.53

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

12.93

5.58

18.0

13.9

5.17

6.96

mmol/l

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

1333

12738

1.61

5.49

31.6

16.5

139.13

139.69

mmol/l

11.52

1318

12505

(3003181) Sodium [Moles/volume] in Urine

252

2.06

5.44

1.4

47.64

60.55

mmol/l

1.58

208

(3000012) Reticulocyte production index

154

2.37

5.43

2.7

2.1

0.97

0.86

0.60

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

2.84

5.42

1.1

0.36

0.90

nmol/l

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

2.84

5.42

1.1

1.4

—

440.00

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

176

1232

1.49

5.40

3.1

4.3

15.20

13.79

ug/l

0.07

134

978

(3024932) HLA-DR beta [Type]

5.22

5.39

1.0

1.1

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

1334

12758

1.61

5.37

32.3

16.6

3.93

3.95

mmol/l

0.77

1315

12496

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

3.57

5.33

1.1

91.63

91.80

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

3.57

5.33

1.1

1.0

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

207

2.16

5.33

1.0

—

(3008898) HLA-B27 [Presence]

517

1.73

5.29

1.0

1.1

—

(3024471) HLA-A [Type]

5.04

5.26

1.0

—

(42528595) U1 small nuclear ribonucleoprotein 70kD Ab [Presence] in Serum by Line blot

+∞

5.21

1.4

0.0

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

3.50

5.18

1.1

89.38

85.56

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

203

2.15

5.17

3.7

3.6

0.83

0.79

nmol/l

0.20

172

(3006184) Hemoglobin [Mass/volume] in Capillary blood

279

1.97

5.12

1.9

2.3

131.14

130.22

g/l

0.10

228

(3025941) Bacteria identified in Stool by Culture

113

726

1.60

5.11

1.3

1.2

—

(3023410) Appearance of Cerebral spinal fluid

140

2.39

5.09

1.4

1.6

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

334

2644

1.34

5.05

1.7

65979832.84

35045485.43

pmol/l

0.27

291

2220

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

367

1.84

5.03

1.1

0.78

6.80

eliau/ml

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

2.66

5.00

4.5

2.5

—

(3000034) Microalbumin [Mass/volume] in Urine

2.66

5.00

4.5

2.6

89.42

12.42

mg/l

0.88

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

6.92

4.95

1.1

1.0

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

5.46

4.91

1.2

1.3

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

923

8371

1.29

4.87

3.8

3.2

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

125

2.43

4.82

1.1

106.47

113.48

pmol/l

0.37

125

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

8.22

4.56

1.1

1.2

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

1272

12109

1.43

4.55

6.7

5.8

1.92

1.87

mu/l

0.73

1220

11335

(4024509) Urine culture

595

1.62

4.54

2.6

2.0

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

242

1.97

4.53

3.0

3.7

581.10

1576.11

u/ml

0.40

227

(3025130) Human papilloma virus identified in Specimen

285

1.89

4.51

2.1

1.9

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

6.70

4.47

1.2

1.3

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

4.09

4.41

1.1

1.3

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

3.22

4.34

1.3

1.1

118.75

109.50

0.60

(3026389) Candida sp identified in Specimen by Organism specific culture

184

2.09

4.33

1.6

1.3

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

2.61

4.32

1.5

1.3

78.96

74.65

umol/l

0.27

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

11.71

4.28

4.9

5.5

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

364

1.76

4.27

1.3

1.2

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

114

2.39

4.25

1.2

1.1

18.72

16.08

u/ml

—

(3024263) Appearance of Synovial fluid

3.06

4.24

2.1

1.7

—

(40768795) Lymph node Pathology biopsy report

134

2.27

4.17

1.3

1.1

—

(3008037) Lactate [Moles/volume] in Venous blood

293

1.84

4.16

2.8

1.18

1.54

mmol/l

5.16

283

(3001019) Free T4 and TSH panel - Serum or Plasma

808

0.54

4.06

1.5

1.7

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

103

1507

0.66

4.05

1.6

1.9

3.20

3.35

ratio

0.57

1141

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

621

1.57

4.04

2.4

2.3

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

364

1.73

4.00

1.3

1.2

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

3.92

4.00

1.1

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

3.81

3.89

1.1

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

250

1.87

3.83

1.3

23.11

25.46

u/l

0.16

206

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

6.03

3.82

1.1

1.4

—

(3036782) Glucose [Moles/volume] in Pleural fluid

114

2.30

3.79

1.4

1.3

7.21

6.39

mmol/l

0.65

107

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

8.79

3.77

1.3

1.1

—

(40760849) Centromere Ab [Presence] in Serum by Immunoblot

12.04

3.76

1.8

1.0

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

12.04

3.76

1.0

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

2.47

3.72

1.2

1.5

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

2.59

3.72

1.3

1.2

—

(3000492) Spirometry study

177

1329

1.38

3.72

1.9

1.5

—

(3035320) C reactive protein [Mass/volume] in Body fluid

2.39

3.66

3.2

2.4

17.98

30.51

mg/l

1.23

(3017569) Oxygen content in Arterial blood

2.76

3.59

3.4

3.2

16.05

16.60

0.27

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

2.52

3.55

1.2

1.3

—

(4015189) Microbial culture of sputum

4.26

3.51

2.6

3.5

—

(42529406) Shigella sp [Presence] in Stool by Culture

371

1.67

3.50

1.3

1.2

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

2.63

3.47

1.2

1.3

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

4.57

3.43

1.8

1.1

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

2.46

3.39

1.1

1638.93

1561.86

miu/ml

0.11

(3014271) Vancomycin [Susceptibility]

3.11

3.37

3.8

2.4

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

2.73

3.32

2.0

1.6

—

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

1132

0.65

3.28

1.4

1.7

3.21

3.47

mmol/l

1.36

781

(3050794) Legionella sp Ab [Presence] in Serum

8.60

3.26

1.0

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

103

2.25

3.23

1.0

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

3.35

3.22

1.2

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

946

8790

1.22

3.21

4.3

3.2

56.36

42.52

u/l

2.32

910

8296

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

4.19

3.19

1.1

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

2.88

3.19

1.1

1.2

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1359

13214

1.49

3.18

28.6

11.5

24.99

24.74

u/l

0.25

1349

12873

(3020564) Creatinine [Moles/volume] in Serum or Plasma

1365

13285

1.51

3.17

41.2

18.4

78.02

71.62

umol/l

5.85

1355

13152

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

437

1.58

3.17

3.4

3.3

673.38

750.91

u/ml

0.04

381

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

2.48

3.13

1.2

1.3

—

(40761536) Microorganisms panel - Urine sediment

142

1059

1.38

3.13

11.1

3.7

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

4.52

3.11

2.4

1.6

—

(3008536) Aspergillus sp Ab [Presence] in Serum

4.31

2.99

1.2

2.1

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

3.87

2.98

1.3

1.2

1.19

mmol/l

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

10.03

2.98

1.0

1.6

—

(3038515) Glucose [Moles/volume] in Venous blood

243

1.75

2.93

3.0

2.9

6.71

7.47

mmol/l

1.36

234

(1616796) Gas panel - Central venous blood

237

1.75

2.87

4.6

3.6

—

(36305075) Vedolizumab [Mass/volume] in Serum or Plasma by Immunoassay

6.69

2.87

7.0

2.1

35.93

25.11

mg/l

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

3.18

2.85

1.2

—

(21494755) Public health laboratory ask at order entry panel

1268

0.70

2.81

1.2

1.3

—

(40757373) Influenza virus identified in Isolate

3.93

2.77

2.0

1.5

—

(3026480) Teichoate Ab [Titer] in Serum

8.36

2.75

1.0

—

(3036670) Protein [Mass/volume] in Synovial fluid

3.25

2.72

1.1

1.3

31.32

37.53

g/l

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

6.02

2.70

2.3

2.7

—

(3015956) Eosinophils/Leukocytes in Blood by Manual count

4.23

2.68

4.9

1.8

1.75

2.63

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

205

1.78

2.67

1.2

1.1

3.80

2.36

eliau/ml

—

(3000330) Specific gravity of Urine by Test strip

606

1.45

2.65

6.5

3.2

1.02

ratio

0.47

552

(3049717) Cytology report of Urine Cyto stain

354

1.58

2.59

2.1

2.5

—

(3040151) Glucose [Moles/volume] in Capillary blood

121

2.00

2.56

2.7

7.3

6.81

7.31

mmol/l

0.38

102

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

2.74

2.55

3.6

2.3

—

(3035880) pH of Pleural fluid

2.61

2.53

1.1

1.2

7.48

7.37

—

(4211845) Urine protein measurement

2.51

2.53

4.8

2.5

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

2.99

2.49

1.2

1.1

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

4.39

2.47

3.4

1.9

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

2.15

2.45

1.5

1.3

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

749

0.64

2.44

1.6

990.52

988.67

mu/l

0.01

615

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

2.25

2.44

1.1

1.2

90.00

78.79

u/l

0.40

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

2.25

2.44

1.1

1.2

18.59

23.83

u/l

0.37

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

160

1.83

2.40

1.0

1.1

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

5.02

2.40

1.2

1.3

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

5.02

2.40

1.0

2.3

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

320

2742

1.21

2.40

1.7

1.6

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

551

1.44

2.39

1.5

1.6

30.51

14.28

u/ml

—

128

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

2.08

2.37

1.8

1.2

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

6.27

2.37

1.4

1.0

—

(3034891) Synovial lining cells/cells in Synovial fluid

2.43

2.37

1.6

1.4

4.60

5.45

—

(3032057) Clostridioides difficile [Presence] in Stool

3.65

2.36

1.9

2.1

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

4.13

2.36

3.3

1.8

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

106

793

1.36

2.35

1.0

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

2.06

2.32

1.8

1.2

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

3.90

2.25

1.3

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

155

1234

1.29

2.24

4.0

3.1

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

114

1.94

2.21

1.9

1.7

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

495

1.44

2.16

1.3

245.13

227.94

miu/ml

0.13

243

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

3.70

2.15

1.1

—

(3035637) Corticotropin [Mass/volume] in Plasma

167

1.75

2.12

1.4

1.6

29.17

24.42

ng/l

0.27

167

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

3.51

2.05

1.1

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

2.51

2.01

3.7

4.7

—

(40765096) Chromosome analysis panel by Banding

2.64

2.00

1.1

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

1220

11801

1.22

2.00

6.7

6.1

38.14

38.84

mmol/mol

1.36

1171

11091

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

2.36

1.95

1.4

1.3

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

4.56

1.94

1.2

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

4.56

1.94

1.2

1.1

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

3.76

1.93

1.2

1.3

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

260

1.55

1.88

2.6

2.4

91.62

95.89

ug/min

0.04

157

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

2.17

1.88

1.6

1.7

1.44

2.29

u/field

—

(3032773) Endomysium IgG Ab [Titer] in Serum

159

1.71

1.86

1.1

—

(3012501) Base excess in Blood by calculation

222

1.59

1.83

4.7

3.8

2.97

2.78

mmol/l

0.15

150

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

4.18

1.82

1.2

1.6

—

(3004451) EKG impression Narrative

2.13

1.82

1.2

1.3

—

(1761482) Bacteria [#/volume] in Urine by Culture

271

1.53

1.80

5.6

4.2

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

3.34

1.74

1.0

1.1

—

(3005532) Lymphocytes/Leukocytes in Pleural fluid

2.68

1.72

1.4

1.3

42.50

58.04

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

1.96

1.70

1.0

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

3.17

1.66

1.0

1.1

—

(3006462) Nitrate [Presence] in Urine

2.25

1.63

5.8

2.7

—

(3051611) Lipemic interference index of Serum or Plasma

113

1.78

1.61

5.6

3.0

15.23

11.46

index

0.80

(3051651) Icteric interference index of Serum or Plasma

2.07

1.60

7.1

3.2

0.38

0.81

index

1.81

(3036071) Salmonella sp Ab [Titer] in Serum

2.33

1.59

1.3

1.1

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

2.28

1.55

1.0

2.3

35.86

41.76

g/l

—

(3044242) Glucose [Moles/volume] in Arterial blood

1.95

1.49

3.8

2.8

6.14

9.43

mmol/l

4.02

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

1244

12126

1.19

1.48

5.3

5.0

5.58

5.85

mmol/l

13.23

1179

11205

(3024869) Neuronal Ab [Presence] in Serum

3.13

1.44

1.0

1.1

—

(3002079) Sodium [Moles/time] in 24 hour Urine

2.04

1.43

1.3

1.5

166.00

150.08

mmol/24h

0.28

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

141

1.64

1.42

1.2

1.1

—

(3050129) First trimester maternal screen panel - Serum or Plasma

493

0.68

1.41

1.4

1.5

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

1.78

1.39

1.6

2.2

1.29

2.47

u/field

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

182

1.55

1.38

1.5

1.3

0.50

0.28

nmol/l

0.30

137

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

128

1531

0.82

1.36

1.8

1.7

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

596

5564

1.12

1.35

2.0

1.9

1.34

mmol/l

0.04

518

4761

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

405

0.66

1.34

1.4

1.5

0.94

0.95

ratio

0.05

261

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

405

0.66

1.34

1.4

1.5

1.24

1.13

ratio

0.20

261

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

405

0.66

1.34

1.4

1.5

1.19

1.21

ratio

0.03

261

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

499

0.69

1.34

1.0

1.1

1.58

1.60

g/l

0.19

499

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

2.15

1.33

1.6

1.3

—

(3029396) Erythrocyte agglutination [Presence] in Blood

2.29

1.27

1.6

3.6

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

398

0.67

1.25

1.4

1.5

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

132

1111

1.21

1.24

1.4

1.2

94.93

143.40

u/ml

1.19

440

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

2.41

1.24

1.2

1.1

0.04

0.02

u/ml

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

512

0.72

1.22

1.1

1.2

0.82

0.88

g/l

0.80

512

(3043238) Trisomy 21 risk [Likelihood] in Fetus

347

0.66

1.20

1.5

1.6

—

(44806420) Estimation of glomerular filtration rate

168

0.53

1.19

2.9

2.3

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

469

0.72

1.11

1.0

1.1

0.50

0.63

ratio

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

703

1.24

1.10

1.7

1.5

—

(3008295) Osmolality of Serum or Plasma

152

1.52

1.09

1.3

1.6

269.81

277.04

mosm/kgh2o

0.62

118

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

360

0.69

1.05

1.6

—

(3022689) Creatine [Moles/volume] in Urine

2.06

1.03

3.1

1.3

7.40

8.64

mmol/l

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

551

0.76

1.01

1.5

1.7

6.62

4.62

mg/l

0.44

410

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

222

1.41

1.01

1.3

1.5

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

333

0.69

1.01

1.5

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

249

1.37

0.98

5.8

4.0

29.70

23.60

mg/l

0.63

172

(4034850) Laboratory test

411

0.72

0.97

33.0

9.6

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

199

1.42

0.96

2.1

2.4

7.10

5.62

umol/l

0.30

136

(44816559) Phosphatidylethanol [Mass/volume] in Blood

525

1.25

0.95

1.7

1.6

0.51

0.33

mg/l

0.84

228

(3003740) Influenza virus B Ag [Presence] in Specimen

268

1.35

0.95

1.1

—

(3002523) Influenza virus A Ag [Presence] in Specimen

268

1.35

0.95

1.1

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

1.77

0.94

2.2

2.5

800.46

20.69

ug/l

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

2.15

0.91

1.5

1.1

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

267

0.67

0.91

1.1

0.76

1.36

u/ml

—

135

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

176

1.43

0.91

1.4

1.3

—

nmol/l

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

377

1.28

0.89

1.5

1.3

10.57

10.94

u/l

0.06

297

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

312

0.70

0.88

1.7

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

986

0.83

0.88

1.3

—

(3047189) Immunofixation for 24 hour Urine

1.79

0.88

1.2

1.7

—

(3001893) Eosinophils/Leukocytes in Pleural fluid

2.00

0.87

1.5

1.3

0.83

3.32

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

1.63

0.84

2.7

1.6

112.32

108.61

ng/l

0.04

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

166

1477

1.14

0.84

1.5

1.7

1.53

1.41

0.87

143

1305

(4094501) Cardiovascular stress test using bicycle ergometer

340

0.73

0.80

1.0

1.1

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

222

0.67

0.77

1.1

1.0

11.75

3.80

u/ml

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

0.00

0.76

0.0

1.2

—

160.01

—

(3023511) Choriogonadotropin [Units/volume] in Urine

346

0.75

0.74

1.3

1.2

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

107

933

1.16

0.74

1.4

36.50

28.40

iu/l

1.40

798

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.80

0.72

2.1

3.5

5.00

4.68

kpa

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.80

0.72

2.1

3.5

9.83

10.45

kpa

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

157

1412

1.13

0.70

6.8

6.2

—

(3002256) Pathology report gross observation

189

1722

1.11

0.68

1.3

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

309

2886

1.09

0.67

1.8

1.5

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

1.63

0.67

1.0

43.99

41.93

iu/ml

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

181

1650

1.11

0.65

4.5

5.1

1.79

2.22

ug/l

0.87

159

1479

(3019832) Treponema pallidum Ab [Presence] in Serum

161

1471

1.11

0.57

1.7

1.8

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

1.46

0.56

3.5

3.2

0.56

1.45

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

1200

11831

1.09

0.55

4.7

4.2

1.25

1.26

mmol/l

0.31

1134

10951

(3023430) Cat dander IgE Ab [Units/volume] in Serum

205

0.73

0.54

1.2

1.1

1.87

5.67

u/ml

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

1258

12432

1.09

0.53

5.4

4.9

1.50

1.53

mmol/l

1.15

1192

11616

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

416

1.18

0.51

1.4

1.5

153.69

206.65

pmol/l

0.37

407

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

324

0.80

0.50

1.1

0.85

1.84

u/ml

0.90

179

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

607

1.14

0.47

1.8

2.1

8485.30

6271.95

u/l

0.15

259

(3008401) Mugwort IgE Ab [Units/volume] in Serum

264

0.79

0.44

1.1

1.48

1.30

u/ml

—

118

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

1261

12483

1.08

0.43

5.5

5.0

4.48

4.75

mmol/l

19.94

1199

11727

(4281824) Cell count and differential, peritoneal fluid

174

0.74

0.43

1.4

1.1

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

890

1.11

0.42

2.0

1.8

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

1.36

0.41

1.2

1.7

4.41

7.86

ug/l

1.74

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

206

0.77

0.41

1.3

1.6

—

(3015616) Isopropanol [Moles/volume] in Serum or Plasma

0.00

0.41

0.0

1.5

—

(3008402) Methanol [Moles/volume] in Serum or Plasma

0.00

0.41

0.0

1.4

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

114

1.32

0.40

1.1

1.2

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

180

1686

1.08

0.40

1.8

2.2

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

1.43

0.39

1.4

1.3

481.40

331.57

pmol/l

—

(4198724) Urine methamphetamine measurement

1.43

0.35

1.0

1.6

—

(44813793) Dust mix specific IgE antibody measurement

1.32

0.35

1.0

1.1

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

255

0.82

0.35

1.3

1.6

55.10

56.58

ug/l

0.11

255

(3011288) Drugs identified in Urine by Screen method Nominal

351

0.85

0.34

1.9

1.7

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

274

0.84

0.32

1.1

5.32

4.27

u/ml

0.13

147

(3021387) Prolactin [Units/volume] in Serum or Plasma

551

1.11

0.31

1.5

1.7

241.85

307.04

mu/l

1.67

494

(3020191) Ethanol [Moles/volume] in Serum or Plasma

0.72

0.31

1.0

1.5

0.60

1.14

promille

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

106

990

1.08

0.28

2.8

3.1

0.76

0.73

ug/l

0.08

625

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

1273

12643

1.06

0.27

6.0

5.7

2.54

2.78

mmol/l

22.76

1205

11835

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

636

1.09

0.26

1.7

1.5

—

(3005570) Glucose [Moles/volume] in Urine

132

1.21

0.25

2.5

2.0

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

0.70

0.24

1.3

—

(3041806) Other cells [#/volume] in Blood by Manual count

1.28

0.23

1.2

1.6

0.42

0.49

e9/l

—

(3043410) Blood group antigens tested for on Red Blood Cells

1.25

0.22

2.0

1.3

—

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

0.00

0.21

0.0

1.2

—

25.20

—

(3007700) Barley IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

0.18

—

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

0.00

0.21

0.0

1.1

—

1.56

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.00

0.21

0.0

1.2

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

0.00

0.21

0.0

6.4

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

2.2

—

49.92

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

0.00

0.20

0.0

1.3

—

5.99

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

590

0.93

0.18

1.5

—

(3003694) ABO and Rh group [Type] in Blood

387

3788

1.03

0.18

1.5

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

1.17

0.17

1.0

1.2

406.14

428.25

u/l

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

195

0.87

0.17

1.1

1.0

0.07

0.28

u/ml

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

0.73

0.17

1.0

—

0.13

—

(3006653) Thiamine [Moles/volume] in Blood

1.16

0.16

1.3

1.5

119.63

140.76

nmol/l

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

159

1537

1.04

0.16

1.8

2.0

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

235

1.11

0.15

1.3

1.2

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

565

1.06

0.15

2.9

2.2

11.85

12.04

nmol/l

0.06

517

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

1.13

0.15

1.2

1.8

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

1.10

0.15

1.6

1.4

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

1.18

0.14

1.1

1.3

—

(3028707) Methadone [Presence] in Urine by Screen method

228

1.10

0.13

1.6

1.5

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

273

0.91

0.13

1.8

0.93

0.87

nmol/l

0.17

229

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

453

1.06

0.12

1.8

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

405

0.94

0.12

1.6

1.4

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

168

0.89

0.11

1.2

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

136

1321

1.03

0.11

3.4

4.3

23.03

21.91

0.32

617

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

112

1085

1.03

0.11

2.2

2.0

—

(40761511) CBC panel - Blood by Automated count

1301

12973

1.03

0.10

25.2

12.9

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

1.14

0.10

1.0

1.2

111.94

149.99

pmol/l

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

1.06

0.09

1.0

—

(3020650) Glucose [Presence] in Urine

1.06

0.09

1.6

2.1

0.00

estimate

—

(3027944) Amphetamines [Presence] in Urine

513

0.95

0.09

1.5

—

(3016879) Cocaine [Presence] in Urine

482

0.95

0.09

1.5

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

1.03

0.08

1.2

1.1

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

0.86

0.07

1.5

1.3

—

1428.62

—

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

0.80

0.07

1.2

15.50

9.49

mm/h

—

(1617658) Protocol used for examination of sentinel lymph nodes

147

1.09

0.07

1.1

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

187

1.07

0.06

1.3

1.2

—

(1002224) Polysomnography panel

672

1.03

0.05

1.1

—

(3027008) Opiates [Presence] in Urine

515

0.97

0.05

1.5

—

(3000963) Hemoglobin [Mass/volume] in Blood

1366

13672

0.98

0.03

51.6

22.4

129.04

133.72

g/l

31.54

1358

13551

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

118

0.93

0.02

1.3

1.5

11.95

8.53

mmol/l

0.47

113

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

441

1.02

0.02

2.0

2.1

7.80

16.89

iu/l

0.31

183

(3010813) Leukocytes [#/volume] in Blood

1366

13670

0.99

0.02

51.3

22.3

6.41

6.61

e9/l

2.83

1350

13390

(3026361) Erythrocytes [#/volume] in Blood

1366

13667

0.99

0.01

51.2

22.2

4.30

4.45

e12/l

27.03

1348

13389

(3035941) MCH [Entitic mass]

1366

13667

0.99

0.01

50.9

22.1

30.26

30.23

0.27

1359

13548

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

1366

13667

0.99

0.01

51.8

22.6

39.01

40.02

14.13

1358

13542

(4146454) Self-monitoring of blood glucose

114

1.05

0.00

4.2

2.7

—

(3024731) MCV [Entitic mean volume] in Red Blood Cells

1366

13664

0.99

0.00

51.0

22.2

91.60

90.95

5.39

1359

13545

(3007461) Platelets [#/volume] in Blood

1366

13662

1.00

0.00

51.3

22.2

252.26

258.84

e9/l

2.91

1352

13427

(40768793) Breast Pathology biopsy report

449

1.00

0.00

1.4

1.3

—

(3028300) Cannabinoids [Presence] in Urine

519

1.00

0.00

1.5

—

(3006270) Folate [Moles/volume] in Blood

1.03

0.00

1.4

1.2

351.07

406.13

nmol/l

—

(3000764) Benzodiazepines [Presence] in Urine

515

0.99

0.00

1.5

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

159

1585

1.00

0.00

1.6

1.5

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

0.92

0.00

1.0

—

0.48

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

0.91

0.00

1.1

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

0.00

-0.00

0.0

1.2

—

30.86

—

(3038864) risperiDONE [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.2

—

80.57

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(40763590) HLA-DQ beta [Type]

0.00

-0.00

0.0

1.0

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

0.00

-0.00

0.0

1.0

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

0.00

-0.00

0.0

1.0

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

0.00

-0.00

0.0

1.0

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

0.00

-0.00

0.0

3.1

—

38.25

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

-0.00

0.0

1.0

—

(3014043) Spermatozoa Nonprogressive/Spermatozoa in Semen

0.00

-0.00

0.0

6.3

—

9.88

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

-0.00

0.0

1.0

—

(40760410) HLA-B [Type] by High resolution

0.00

-0.00

0.0

1.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

(46236302) HLA-C [Type] by High resolution typing

0.00

-0.00

0.0

1.0

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

0.91

-0.00

1.0

1.1

—

(3023436) Glucagon [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

2.4

—

181.43

—

(42868555) Amyloid beta 40 peptide [Mass/volume] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(3039443) Prostate specific Ag panel - Serum or Plasma

110

1.00

-0.00

1.2

1.5

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.7

—

527.35

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

0.00

-0.00

0.0

1.0

—

(3023530) 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

1.76

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

-0.00

0.0

2.0

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

2.1

—

319.63

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.7

—

315.29

—

(3018081) Beta-2-Microglobulin [Mass/volume] in Urine

0.00

-0.00

0.0

1.7

—

7.80

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

0.00

-0.00

0.0

1.5

—

(40760409) HLA-A [Type] by High resolution

0.00

-0.00

0.0

1.0

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

0.94

-0.00

1.6

1.7

67.66

592.36

nmol/24h

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

0.00

—

(40768800) Prostate Pathology biopsy report

0.95

-0.00

1.2

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: M13_SLE – Systemic lupus erythematosus

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Systemic lupus erythematosus

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Systemic lupus erythematosus (M13_SLE)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints